data_2k7d_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k7d _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' C ' ' OE1' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.621 ' OD2' ' N ' ' A' ' 115' ' ' GLY . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.473 HG21 ' CE1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.508 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 144' ' ' ILE . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.606 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.606 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 149' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.144 0.497 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.473 ' CD2' ' CD1' ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.46 ' OD2' ' OE2' ' A' ' 123' ' ' GLU . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' OE2' ' OD2' ' A' ' 116' ' ' ASP . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.436 ' CB ' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.459 HH11 HD12 ' A' ' 132' ' ' LEU . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.459 HD12 HH11 ' A' ' 129' ' ' ARG . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.446 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.436 HD13 ' CB ' ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 146' ' ' ARG . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' PHE . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.667 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.168 0.508 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.463 ' N ' HG21 ' A' ' 119' ' ' ILE . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.744 ' HG1' ' H ' ' A' ' 122' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.744 ' H ' ' HG1' ' A' ' 121' ' ' THR . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 130' ' ' LYS . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.74 ' HD1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.43 ' CD1' ' ND2' ' A' ' 151' ' ' ASN . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.43 ' ND2' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 148' ' ' VAL . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 161' ' ' PHE . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.007 0.432 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.509 HG22 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.509 HD21 HG22 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.482 HD11 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 121' ' ' THR . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.683 ' H ' ' CD2' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 121' ' ' THR . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.761 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.415 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.434 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.987 0.422 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.613 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.458 ' NH1' ' HG3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.547 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.448 ' SD ' HD13 ' A' ' 124' ' ' LEU . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.501 ' N ' ' CG1' ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.632 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.632 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.632 ' CG ' ' H ' ' A' ' 152' ' ' GLY . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.632 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.563 ' CG ' HD22 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . 0.44 ' C ' ' OD1' ' A' ' 157' ' ' ASP . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.616 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 102' ' ' LYS . 1.8 p . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.146 0.498 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.497 ' H ' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 128' ' ' MET . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.51 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.51 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.666 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.666 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.52 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.52 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.448 ' SD ' HD12 ' A' ' 124' ' ' LEU . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.404 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.652 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 8.8 p80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.558 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 155' ' ' ARG . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' ASP . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.241 0.543 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.582 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.444 ' CE1' HD12 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.536 HD22 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.424 ' SD ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 2.2 p80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.418 HG22 ' SD ' ' A' ' 164' ' ' MET . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.433 ' HE ' ' HG ' ' A' ' 120' ' ' SER . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.582 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.418 ' SD ' HG22 ' A' ' 148' ' ' VAL . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.925 HD21 ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.419 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' CE1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 122' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.524 ' H ' ' HG1' ' A' ' 121' ' ' THR . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.523 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 125' ' ' ARG . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.404 HD12 ' CB ' ' A' ' 124' ' ' LEU . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.502 ' CE1' ' HE1' ' A' ' 165' ' ' MET . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 158' ' ' PHE . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.502 ' HE1' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.948 0.404 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 107' ' ' ALA . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.615 ' HG ' HH21 ' A' ' 155' ' ' ARG . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' ARG . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 135' ' ' GLN . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.64 ' HD1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.64 ' N ' ' HD1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.665 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.615 HH21 ' HG ' ' A' ' 120' ' ' SER . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.708 0.289 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.45 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' A' ' 129' ' ' ARG . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 129' ' ' ARG . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.597 ' CD1' ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.787 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' ND2' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.798 HD21 ' H ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.798 ' H ' HD21 ' A' ' 151' ' ' ASN . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.009 0.433 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.603 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.646 ' HZ1' ' CB ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.532 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 m-70 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.482 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.754 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.754 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.665 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 153' ' ' ASP . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.631 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.445 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.474 HH11 ' CG ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.187 0.517 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.791 ' H ' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.649 ' H ' ' HG1' ' A' ' 121' ' ' THR . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.55 ' N ' ' CD2' ' A' ' 138' ' ' HIS . 10.0 m170 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m . . . . . 0 C--O 1.206 -1.213 0 CA-C-O 120.66 0.267 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 114' ' ' ASN . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 116' ' ' ASP . 0.3 OUTLIER -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.74 ' N ' ' ND2' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.764 ' N ' ' ND2' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . 0.563 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.563 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.5 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . 0.488 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HE ' ' HG ' ' A' ' 120' ' ' SER . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.472 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 157' ' ' ASP . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.252 0.549 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.667 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 111' ' ' PHE . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 121' ' ' THR . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.467 ' N ' ' HG ' ' A' ' 120' ' ' SER . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.42 ' NE2' HG21 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 121' ' ' THR . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.832 0.348 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.96 131.07 15.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.814 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -173.37 3.94 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.435 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.6 mp -45.38 151.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.824 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 99' ' ' ILE . . . 146.08 -83.43 0.19 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -87.11 -16.08 9.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.623 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' C ' ' OE1' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.467 HH11 ' HG2' ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.708 ' OD1' 'CA ' ' A' ' 501' ' ' ' CA' . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.473 HG21 ' CE1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.467 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.467 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.508 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.52 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.456 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.456 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.456 ' H ' ' HG3' ' A' ' 139' ' ' ARG . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.447 ' N ' HD13 ' A' ' 144' ' ' ILE . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.412 ' O ' ' CG2' ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.606 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.606 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 159' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.54 ' CG ' ' OD1' ' A' ' 149' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . 0.708 'CA ' ' OD1' ' A' ' 112' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.758 0.313 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' CG ' ' C ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 68.09 129.92 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.72 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttt -68.49 83.82 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.531 ' CD1' ' C ' ' A' ' 99' ' ' ILE . 2.3 pp -60.32 -165.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.479 ' N ' HD11 ' A' ' 99' ' ' ILE . . . -152.36 160.49 28.96 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.692 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t -68.08 -9.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.667 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.473 ' CD2' ' CD1' ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.473 ' CD1' ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.421 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 120' ' ' SER . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.436 ' CB ' HD13 ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.459 HH11 HD12 ' A' ' 132' ' ' LEU . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.459 HD12 HH11 ' A' ' 129' ' ' ARG . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.446 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.446 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.436 HD13 ' CB ' ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 146' ' ' ARG . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 161' ' ' PHE . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.471 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.484 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.667 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.509 ' SD ' ' O ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -89.86 154.15 20.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.41 121.8 16.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.599 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.594 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -60.67 -169.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.326 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 102' ' ' LYS . . . 147.65 -50.69 0.58 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.621 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' GLY . 4.2 p -41.65 -23.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.471 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.463 ' N ' HG21 ' A' ' 119' ' ' ILE . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.744 ' HG1' ' H ' ' A' ' 122' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.744 ' H ' ' HG1' ' A' ' 121' ' ' THR . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.452 ' O ' ' NZ ' ' A' ' 130' ' ' LYS . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.456 ' HB2' ' NZ ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.74 ' HD1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.578 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.43 ' CD1' ' ND2' ' A' ' 151' ' ' ASN . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.43 ' ND2' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.443 ' SD ' HG23 ' A' ' 148' ' ' VAL . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.457 ' HE2' ' CE1' ' A' ' 161' ' ' PHE . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.837 0.351 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -78.16 147.3 34.59 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.838 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 tpp -170.04 10.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 tp -44.93 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.739 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.478 ' C ' ' H ' ' A' ' 102' ' ' LYS . . . 170.42 100.25 0.13 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.492 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -48.95 -12.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.828 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.482 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.509 HG22 HD21 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.509 HD21 HG22 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.482 HD11 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.506 ' H ' ' HG1' ' A' ' 121' ' ' THR . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.468 HD13 ' SD ' ' A' ' 128' ' ' MET . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.468 ' SD ' HD13 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.574 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.683 ' H ' ' CD2' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.433 ' CD1' ' HA ' ' A' ' 121' ' ' THR . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.761 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.761 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.415 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.434 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.42 -50.89 0.19 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.675 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.1 mtt -49.12 -21.21 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.744 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.5 mt -71.81 -51.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.769 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 108.12 43.3 1.3 Allowed Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.83 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 24.2 t -82.13 -70.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.222 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.616 ' CD1' ' CZ ' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.613 ' N ' ' OD1' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.458 ' NH1' ' HG3' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.547 ' CG ' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.547 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.47 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.448 ' SD ' HD13 ' A' ' 124' ' ' LEU . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.501 ' CG1' ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.501 ' N ' ' CG1' ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 149' ' ' ASP . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.632 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.632 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.632 ' CG ' ' H ' ' A' ' 152' ' ' GLY . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.632 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.563 ' CG ' HD22 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . 0.44 ' C ' ' OD1' ' A' ' 157' ' ' ASP . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.435 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.616 ' CZ ' ' CD1' ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.06 81.44 6.32 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.94 112.7 3.05 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.69 -76.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.28 -15.5 0.06 OUTLIER Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.421 HG13 ' N ' ' A' ' 102' ' ' LYS . 1.8 p -59.55 -24.97 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.812 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.596 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.497 ' H ' ' HG1' ' A' ' 121' ' ' THR . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.422 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 128' ' ' MET . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.45 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.51 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.51 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.441 ' CD1' ' N ' ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.666 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.666 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.519 ' O ' ' N ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 98' ' ' MET . 10.4 t70 -145.38 162.06 38.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.485 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.1 mtt -84.27 124.66 31.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 mm -65.87 153.27 8.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' GLU . . . -92.79 -51.7 2.25 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t -43.55 -70.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.686 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 101' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.52 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.52 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.486 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.404 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.448 ' SD ' HD12 ' A' ' 124' ' ' LEU . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.404 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.457 ' N ' HD12 ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.652 ' CD ' ' H ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 8.8 p80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.418 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.454 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.433 HD11 ' CD2' ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.558 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.552 ' OD1' ' N ' ' A' ' 155' ' ' ARG . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.552 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.426 ' O ' ' N ' ' A' ' 159' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' ASP . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.5 ' N ' ' SD ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.74 97.64 11.31 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ttt -44.19 127.77 5.71 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 99' ' ' ILE . 1.7 mp -60.81 146.1 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.643 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.57 15.79 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.68 -43.2 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.582 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.444 ' CE1' HD12 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.536 HD22 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 HD12 ' CE1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.424 ' SD ' HD12 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.445 ' N ' HD13 ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 2.2 p80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.418 HG22 ' SD ' ' A' ' 164' ' ' MET . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.433 ' HE ' ' HG ' ' A' ' 120' ' ' SER . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.582 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.418 ' SD ' HG22 ' A' ' 148' ' ' VAL . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.6 -93.59 0.2 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 98' ' ' MET . 0.5 OUTLIER 50.31 -169.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.978 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 100' ' ' GLY . 4.4 tp -79.06 157.72 4.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.666 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.476 ' N ' HG13 ' A' ' 99' ' ' ILE . . . -71.02 12.62 2.13 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.156 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 99' ' ' ILE . 27.0 t -68.49 -40.36 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.538 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.487 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.469 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.925 HD21 ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.419 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.469 HD11 ' CE1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.524 ' HG1' ' H ' ' A' ' 122' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.524 ' H ' ' HG1' ' A' ' 121' ' ' THR . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.523 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.428 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.47 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.464 ' CG2' ' N ' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.428 ' CD1' ' HA ' ' A' ' 125' ' ' ARG . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.404 HD12 ' CB ' ' A' ' 124' ' ' LEU . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.665 ' OD1' 'CA ' ' A' ' 502' ' ' ' CA' . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.502 ' CE1' ' HE1' ' A' ' 165' ' ' MET . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.466 ' CG2' ' CE1' ' A' ' 158' ' ' PHE . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.502 ' HE1' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . 0.665 'CA ' ' OD1' ' A' ' 149' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.475 ' C ' ' OD1' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.794 0.331 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 96' ' ' ALA . 1.7 m-20 -149.39 -122.58 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ttt -87.9 -14.66 38.74 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 17.0 mt -149.45 121.68 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.963 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.481 ' H ' ' HG3' ' A' ' 103' ' ' GLU . . . -120.64 168.21 13.94 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.418 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m -48.06 -36.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.234 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.481 ' HG3' ' H ' ' A' ' 100' ' ' GLY . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' O ' ' N ' ' A' ' 107' ' ' ALA . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.577 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.523 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.615 ' HG ' HH21 ' A' ' 155' ' ' ARG . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.461 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.469 HD12 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.408 ' O ' ' N ' ' A' ' 129' ' ' ARG . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.471 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.432 ' H ' ' HB3' ' A' ' 135' ' ' GLN . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.64 ' HD1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.64 ' N ' ' HD1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.478 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.665 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.444 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.665 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.615 HH21 ' HG ' ' A' ' 120' ' ' SER . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.436 ' HA ' ' CD1' ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.444 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 31.3 p-10 -72.09 -1.98 16.81 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.632 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.431 ' O ' ' CG2' ' A' ' 99' ' ' ILE . 92.1 mt -144.82 -6.21 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.704 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.01 98.6 0.31 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.449 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p -80.11 -46.01 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.469 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.444 ' CD1' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.462 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.444 HD11 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.45 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.597 ' SD ' ' CD1' ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' A' ' 129' ' ' ARG . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 129' ' ' ARG . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.597 ' CD1' ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.445 HG21 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.445 ' N ' HG21 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.787 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' ND2' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.798 HD21 ' H ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.798 ' H ' HD21 ' A' ' 151' ' ' ASN . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.429 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.751 0.31 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -105.05 88.29 2.84 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -101.54 -178.75 3.82 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.764 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.442 HG23 ' N ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 63.66 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.759 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.442 ' N ' HG23 ' A' ' 99' ' ' ILE . . . 173.94 117.87 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.292 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m -68.33 -16.95 21.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.979 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.603 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' N ' ' O ' ' A' ' 121' ' ' THR . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.646 ' HZ1' ' CB ' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.532 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 m-70 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.482 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.484 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.754 ' CG1' ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.754 ' H ' ' CG1' ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.665 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.405 ' H ' ' H ' ' A' ' 153' ' ' ASP . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.631 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.631 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.445 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.474 HH11 ' CG ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.79 0.329 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.04 -62.83 1.47 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.15 74.67 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.724 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mm 48.62 54.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.659 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.58 71.69 0.35 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.075 -1.536 . . . . 0.0 111.464 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -83.78 -15.69 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.094 179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.791 ' H ' ' ND2' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.528 ' CD1' ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.649 ' HG1' ' H ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.649 ' H ' ' HG1' ' A' ' 121' ' ' THR . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.518 ' O ' ' N ' ' A' ' 127' ' ' ALA . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' MET . . . . . 0.458 ' SD ' HD22 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.55 ' N ' ' CD2' ' A' ' 138' ' ' HIS . 10.0 m170 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.591 ' N ' ' OD1' ' A' ' 147' ' ' ASP . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.533 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.584 HH11 ' CG ' ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.1 -39.06 79.21 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mmm -72.84 113.11 9.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 tp -92.76 -8.46 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.86 58.89 3.48 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.626 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m -55.96 -30.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.663 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.503 ' CE1' HD11 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.427 ' C ' ' H ' ' A' ' 114' ' ' ASN . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 116' ' ' ASP . 0.3 OUTLIER -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.74 ' N ' ' ND2' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.764 ' N ' ' ND2' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.503 HD11 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.635 ' CD1' ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.635 ' N ' ' CD1' ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . 0.563 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.563 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.5 ' H ' ' HD1' ' A' ' 138' ' ' HIS . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.426 ' OE1' ' N ' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.435 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.488 ' CG1' ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.488 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.492 ' HE ' ' HG ' ' A' ' 120' ' ' SER . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.472 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 157' ' ' ASP . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.472 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.602 ' C ' ' H ' ' A' ' 98' ' ' MET . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.3 15.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.602 ' H ' ' C ' ' A' ' 96' ' ' ALA . 81.6 mmm -124.09 90.49 3.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.5 pp -96.08 14.34 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.155 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 102' ' ' LYS . . . -53.39 156.08 5.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m -43.55 -25.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.471 ' CG ' HD12 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.667 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . 0.667 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.471 HD12 ' CG ' ' A' ' 111' ' ' PHE . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.467 ' HG ' ' N ' ' A' ' 121' ' ' THR . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.467 ' N ' ' HG ' ' A' ' 120' ' ' SER . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.479 ' C ' ' CD1' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.438 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.405 HG13 ' H ' ' A' ' 137' ' ' GLY . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.431 ' C ' ' H ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.42 ' NE2' HG21 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . 0.431 ' H ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 121' ' ' THR . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.423 ' O ' ' N ' ' A' ' 161' ' ' PHE . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.487 HH11 ' HG2' ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' OE1' ' C ' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.621 ' OD2' ' N ' ' A' ' 115' ' ' GLY . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 144' ' ' ILE . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.491 HD13 ' O ' ' A' ' 140' ' ' ASP . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.642 ' O ' HD21 ' A' ' 150' ' ' LEU . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.946 HG13 ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.946 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.594 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.144 0.497 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.46 ' OD2' ' OE2' ' A' ' 123' ' ' GLU . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.45 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' OE2' ' OD2' ' A' ' 116' ' ' ASP . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.452 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.69 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 156' ' ' VAL . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.697 HG22 HG11 ' A' ' 148' ' ' VAL . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 162' ' ' VAL . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.735 ' CE2' HD12 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 158' ' ' PHE . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.509 ' O ' ' SD ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.168 0.508 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.802 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 113' ' ' THR . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 121' ' ' THR . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 120' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.818 HD11 ' SD ' ' A' ' 128' ' ' MET . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.818 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.591 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.584 HG11 HG22 ' A' ' 156' ' ' VAL . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.584 HG22 HG11 ' A' ' 148' ' ' VAL . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.007 0.432 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.501 HD22 HG23 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.433 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.626 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 124' ' ' LEU . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.916 HG13 ' N ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.916 ' N ' HG13 ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.463 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 148' ' ' VAL . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.608 ' CE2' HD12 ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 158' ' ' PHE . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 102' ' ' LYS . 24.2 t . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.987 0.422 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 101' ' ' VAL . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.725 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' NH1' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.503 HG21 ' OE2' ' A' ' 126' ' ' GLU . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.562 ' H ' ' ND2' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 111' ' ' PHE . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' HG21 ' A' ' 113' ' ' THR . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.408 ' HB2' ' NH1' ' A' ' 139' ' ' ARG . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.588 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 153' ' ' ASP . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 148' ' ' VAL . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.487 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 104' ' ' LEU . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.146 0.498 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 116' ' ' ASP . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 114' ' ' ASN . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HE ' HG12 ' A' ' 141' ' ' ILE . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.842 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 130' ' ' LYS . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB2' ' SD ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.413 ' CG ' HH11 ' A' ' 125' ' ' ARG . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.497 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.497 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.918 HG13 ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.918 ' N ' HG13 ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.564 ' HG2' HD21 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.621 HD12 HG22 ' A' ' 162' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.761 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.761 HD13 ' CE1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.733 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 42.4 p-80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 141' ' ' ILE . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.637 HD11 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.662 ' N ' HG13 ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 162' ' ' VAL . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.621 HG22 HD12 ' A' ' 104' ' ' LEU . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.241 0.543 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.424 ' C ' HD12 ' A' ' 131' ' ' LEU . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.548 ' C ' HG23 ' A' ' 136' ' ' VAL . 30.0 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.45 HD11 HD23 ' A' ' 124' ' ' LEU . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 160' ' ' GLU . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.503 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 1.5 p-10 -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.426 ' OE2' ' ND2' ' A' ' 114' ' ' ASN . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' HD23 ' A' ' 132' ' ' LEU . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 131' ' ' LEU . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.486 ' C ' HG12 ' A' ' 136' ' ' VAL . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 142' ' ' GLU . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 141' ' ' ILE . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 156' ' ' VAL . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.471 ' OD1' ' ND2' ' A' ' 151' ' ' ASN . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.471 ' ND2' ' OD1' ' A' ' 149' ' ' ASP . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.411 ' OD2' ' ND2' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 148' ' ' VAL . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.452 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 104' ' ' LEU . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.425 ' HE3' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.948 0.404 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD12 HG22 ' A' ' 162' ' ' VAL . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.711 HD13 ' CE1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.511 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.51 HD11 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.51 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 136' ' ' VAL . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.874 HG22 HD12 ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.708 0.289 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 162' ' ' VAL . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.622 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.622 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.692 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.789 ' SD ' HD11 ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 131' ' ' LEU . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 130' ' ' LYS . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.789 HD11 ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 139' ' ' ARG . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 124' ' ' LEU . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.523 HG22 HG11 ' A' ' 148' ' ' VAL . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.507 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.63 ' O ' HG23 ' A' ' 162' ' ' VAL . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 104' ' ' LEU . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.009 0.433 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 111' ' ' PHE . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.563 ' HG3' HG22 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 128' ' ' MET . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.897 ' H ' HG13 ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.638 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.668 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.729 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.46 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.499 ' HG2' HH11 ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.187 0.517 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.714 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.854 ' ND2' ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.714 HD13 ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.534 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.837 HD21 ' SD ' ' A' ' 128' ' ' MET . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 136' ' ' VAL . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 144' ' ' ILE . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.665 HG11 ' CG2' ' A' ' 156' ' ' VAL . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.665 ' CG2' HG11 ' A' ' 148' ' ' VAL . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.611 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m . . . . . 0 C--O 1.206 -1.213 0 CA-C-O 120.66 0.267 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 162' ' ' VAL . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 115' ' ' GLY . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 23.0 p30 -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.62 ' N ' ' OD1' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 114' ' ' ASN . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 131' ' ' LEU . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.809 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLN . . . . . 0.531 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.531 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.55 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 162' ' ' VAL . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.805 HG22 HD12 ' A' ' 104' ' ' LEU . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.252 0.549 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.643 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.643 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 124' ' ' LEU . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 124' ' ' LEU . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' CB ' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' C ' ' N ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.464 ' NE2' HG22 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 124' ' ' LEU . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 120' ' ' SER . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.406 HG22 ' HG ' ' A' ' 104' ' ' LEU . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.832 0.348 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.96 131.07 15.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.814 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -173.37 3.94 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.6 mp -45.38 151.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.824 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 99' ' ' ILE . . . 146.08 -83.43 0.19 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -87.11 -16.08 9.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.623 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' OE1' ' C ' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.708 ' OD1' 'CA ' ' A' ' 501' ' ' ' CA' . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 144' ' ' ILE . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.491 HD13 ' O ' ' A' ' 140' ' ' ASP . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.642 ' O ' HD21 ' A' ' 150' ' ' LEU . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.946 HG13 ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.946 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.594 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . 0.708 'CA ' ' OD1' ' A' ' 112' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.758 0.313 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' CG ' ' C ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 68.09 129.92 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.72 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttt -68.49 83.82 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.758 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.3 pp -60.32 -165.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.36 160.49 28.96 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.692 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t -68.08 -9.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.45 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 120' ' ' SER . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.452 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.69 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 156' ' ' VAL . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.697 HG22 HG11 ' A' ' 148' ' ' VAL . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 162' ' ' VAL . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.735 ' CE2' HD12 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 158' ' ' PHE . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.509 ' O ' ' SD ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -89.86 154.15 20.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.41 121.8 16.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.599 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -60.67 -169.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.326 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 102' ' ' LYS . . . 147.65 -50.69 0.58 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.621 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' GLY . 4.2 p -41.65 -23.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.802 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 113' ' ' THR . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 121' ' ' THR . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 120' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.818 HD11 ' SD ' ' A' ' 128' ' ' MET . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.818 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.591 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.584 HG11 HG22 ' A' ' 156' ' ' VAL . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.43 ' ND2' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.584 HG22 HG11 ' A' ' 148' ' ' VAL . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.837 0.351 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -78.16 147.3 34.59 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.838 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 tpp -170.04 10.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 99' ' ' ILE . 4.0 tp -44.93 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 102' ' ' LYS . . . 170.42 100.25 0.13 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.492 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -48.95 -12.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.828 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.501 HD22 HG23 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.433 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.626 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.407 ' C ' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 124' ' ' LEU . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.916 HG13 ' N ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.916 ' N ' HG13 ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.463 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 148' ' ' VAL . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.608 ' CE2' HD12 ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 158' ' ' PHE . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.42 -50.89 0.19 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.675 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.1 mtt -49.12 -21.21 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.744 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 99' ' ' ILE . 6.5 mt -71.81 -51.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.769 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 104' ' ' LEU . . . 108.12 43.3 1.3 Allowed Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 102' ' ' LYS . 24.2 t -82.13 -70.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 101' ' ' VAL . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.725 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' NH1' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.503 HG21 ' OE2' ' A' ' 126' ' ' GLU . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.562 ' H ' ' ND2' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 111' ' ' PHE . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' HG21 ' A' ' 113' ' ' THR . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.408 ' HB2' ' NH1' ' A' ' 139' ' ' ARG . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.588 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 153' ' ' ASP . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 148' ' ' VAL . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.487 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 104' ' ' LEU . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.06 81.44 6.32 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.94 112.7 3.05 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.69 -76.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.28 -15.5 0.06 OUTLIER Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.55 -24.97 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.812 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 116' ' ' ASP . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 114' ' ' ASN . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HE ' HG12 ' A' ' 141' ' ' ILE . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.842 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 130' ' ' LYS . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB2' ' SD ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.413 ' CG ' HH11 ' A' ' 125' ' ' ARG . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.497 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.497 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.918 HG13 ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.918 ' N ' HG13 ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.564 ' HG2' HD21 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 98' ' ' MET . 10.4 t70 -145.38 162.06 38.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.485 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.1 mtt -84.27 124.66 31.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 mm -65.87 153.27 8.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' GLU . . . -92.79 -51.7 2.25 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t -43.55 -70.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.686 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.621 HD12 HG22 ' A' ' 162' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.761 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.761 HD13 ' CE1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.733 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 42.4 p-80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 141' ' ' ILE . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.637 HD11 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.662 ' N ' HG13 ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 162' ' ' VAL . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.621 HG22 HD12 ' A' ' 104' ' ' LEU . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.74 97.64 11.31 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ttt -44.19 127.77 5.71 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.7 mp -60.81 146.1 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.643 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.57 15.79 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.68 -43.2 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.424 ' C ' HD12 ' A' ' 131' ' ' LEU . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.548 ' C ' HG23 ' A' ' 136' ' ' VAL . 30.0 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.45 HD11 HD23 ' A' ' 124' ' ' LEU . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 160' ' ' GLU . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.6 -93.59 0.2 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 98' ' ' MET . 0.5 OUTLIER 50.31 -169.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.978 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 101' ' ' VAL . 4.4 tp -79.06 157.72 4.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.666 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' N ' HG13 ' A' ' 99' ' ' ILE . . . -71.02 12.62 2.13 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.156 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 99' ' ' ILE . 27.0 t -68.49 -40.36 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.538 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.503 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 114' ' ' ASN . 1.5 p-10 -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.426 ' OE2' ' ND2' ' A' ' 114' ' ' ASN . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' HD23 ' A' ' 132' ' ' LEU . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 131' ' ' LEU . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.486 ' C ' HG12 ' A' ' 136' ' ' VAL . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 142' ' ' GLU . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 141' ' ' ILE . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 156' ' ' VAL . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.665 ' OD1' 'CA ' ' A' ' 502' ' ' ' CA' . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 148' ' ' VAL . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 104' ' ' LEU . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.425 ' HE3' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . 0.665 'CA ' ' OD1' ' A' ' 149' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.475 ' C ' ' OD1' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.794 0.331 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 96' ' ' ALA . 1.7 m-20 -149.39 -122.58 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ttt -87.9 -14.66 38.74 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 99' ' ' ILE . 17.0 mt -149.45 121.68 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.523 ' H ' ' HG3' ' A' ' 103' ' ' GLU . . . -120.64 168.21 13.94 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.418 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m -48.06 -36.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.234 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 100' ' ' GLY . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD12 HG22 ' A' ' 162' ' ' VAL . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.711 HD13 ' CE1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.511 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.51 HD11 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.51 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 136' ' ' VAL . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.469 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.874 HG22 HD12 ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 31.3 p-10 -72.09 -1.98 16.81 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.632 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 99' ' ' ILE . 92.1 mt -144.82 -6.21 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.704 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.01 98.6 0.31 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.449 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p -80.11 -46.01 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 162' ' ' VAL . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.622 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.622 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.692 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.789 ' SD ' HD11 ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 131' ' ' LEU . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 130' ' ' LYS . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.789 HD11 ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 139' ' ' ARG . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 124' ' ' LEU . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.523 HG22 HG11 ' A' ' 148' ' ' VAL . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.507 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.63 ' O ' HG23 ' A' ' 162' ' ' VAL . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 104' ' ' LEU . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.751 0.31 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -105.05 88.29 2.84 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -101.54 -178.75 3.82 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.764 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 63.66 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.759 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 99' ' ' ILE . . . 173.94 117.87 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.292 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 101' ' ' VAL . 3.6 m -68.33 -16.95 21.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.979 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 111' ' ' PHE . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.563 ' HG3' HG22 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.7 m80 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 128' ' ' MET . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.897 ' H ' HG13 ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.668 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.729 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.46 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.499 ' HG2' HH11 ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.79 0.329 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.04 -62.83 1.47 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.15 74.67 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.724 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mm 48.62 54.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.659 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.58 71.69 0.35 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.075 -1.536 . . . . 0.0 111.464 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -83.78 -15.69 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.094 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.714 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.854 ' ND2' ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.714 HD13 ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.534 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.837 HD21 ' SD ' ' A' ' 128' ' ' MET . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 136' ' ' VAL . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 144' ' ' ILE . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.665 HG11 ' CG2' ' A' ' 156' ' ' VAL . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.665 ' CG2' HG11 ' A' ' 148' ' ' VAL . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.611 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.1 -39.06 79.21 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mmm -72.84 113.11 9.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 tp -92.76 -8.46 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.86 58.89 3.48 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.626 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m -55.96 -30.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.663 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 162' ' ' VAL . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 115' ' ' GLY . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.62 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 23.0 p30 -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.592 ' N ' ' OD1' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.62 ' N ' ' OD1' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.471 ' OE2' ' ND2' ' A' ' 114' ' ' ASN . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 131' ' ' LEU . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.809 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . 0.531 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.531 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.55 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 162' ' ' VAL . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.805 HG22 HD12 ' A' ' 104' ' ' LEU . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 98' ' ' MET . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.3 15.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 96' ' ' ALA . 81.6 mmm -124.09 90.49 3.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.457 ' H ' HG13 ' A' ' 99' ' ' ILE . 2.5 pp -96.08 14.34 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.155 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 102' ' ' LYS . . . -53.39 156.08 5.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m -43.55 -25.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.643 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.643 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 124' ' ' LEU . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 124' ' ' LEU . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' CB ' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' C ' ' N ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.464 ' NE2' HG22 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 124' ' ' LEU . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 120' ' ' SER . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.406 HG22 ' HG ' ' A' ' 104' ' ' LEU . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 121.077 0.465 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' OE1' ' C ' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.621 ' OD2' ' N ' ' A' ' 115' ' ' GLY . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 144' ' ' ILE . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.491 HD13 ' O ' ' A' ' 140' ' ' ASP . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.642 ' O ' HD21 ' A' ' 150' ' ' LEU . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.946 HG13 ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.946 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.594 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 121.144 0.497 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.46 ' OD2' ' OE2' ' A' ' 123' ' ' GLU . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.45 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.46 ' OE2' ' OD2' ' A' ' 116' ' ' ASP . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.452 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.69 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 156' ' ' VAL . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.697 HG22 HG11 ' A' ' 148' ' ' VAL . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 162' ' ' VAL . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.735 ' CE2' HD12 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 158' ' ' PHE . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.509 ' O ' ' SD ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.488 1.474 0 CA-C-O 121.168 0.508 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.802 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 113' ' ' THR . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 121' ' ' THR . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 120' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.818 HD11 ' SD ' ' A' ' 128' ' ' MET . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.818 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.591 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.584 HG11 HG22 ' A' ' 156' ' ' VAL . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.43 ' ND2' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.584 HG22 HG11 ' A' ' 148' ' ' VAL . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m . . . . . 0 N--CA 1.485 1.277 0 CA-C-O 121.007 0.432 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.608 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.501 HD22 HG23 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.433 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.626 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.721 ' CD2' ' H ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 124' ' ' LEU . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.916 HG13 ' N ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.916 ' N ' HG13 ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.463 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 148' ' ' VAL . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.608 ' CE2' HD12 ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 158' ' ' PHE . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 102' ' ' LYS . 24.2 t . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.987 0.422 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 101' ' ' VAL . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.725 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' NH1' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.503 HG21 ' OE2' ' A' ' 126' ' ' GLU . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.562 ' H ' ' ND2' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 111' ' ' PHE . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' HG21 ' A' ' 113' ' ' THR . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.408 ' HB2' ' NH1' ' A' ' 139' ' ' ARG . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.588 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 153' ' ' ASP . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 148' ' ' VAL . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.487 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 104' ' ' LEU . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.483 1.199 0 CA-C-O 121.146 0.498 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 116' ' ' ASP . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 114' ' ' ASN . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HE ' HG12 ' A' ' 141' ' ' ILE . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.842 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 130' ' ' LYS . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB2' ' SD ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.413 ' CG ' HH11 ' A' ' 125' ' ' ARG . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.497 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.497 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.918 HG13 ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.918 ' N ' HG13 ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.564 ' HG2' HD21 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.763 0.316 . . . . 0.0 110.686 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.621 HD12 HG22 ' A' ' 162' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.761 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.761 HD13 ' CE1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.733 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 8.8 p80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 141' ' ' ILE . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.637 HD11 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.662 ' N ' HG13 ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 162' ' ' VAL . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.621 HG22 HD12 ' A' ' 104' ' ' LEU . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 121.241 0.543 . . . . 0.0 110.847 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.424 ' C ' HD12 ' A' ' 131' ' ' LEU . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 2.2 p80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.548 ' C ' HG23 ' A' ' 136' ' ' VAL . 4.6 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.45 HD11 HD23 ' A' ' 124' ' ' LEU . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 160' ' ' GLU . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 27.0 t . . . . . 0 N--CA 1.488 1.469 0 CA-C-O 121.207 0.527 . . . . 0.0 110.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.551 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.91 HD22 ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.409 ' CD ' HD21 ' A' ' 114' ' ' ASN . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' HD23 ' A' ' 132' ' ' LEU . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 131' ' ' LEU . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.486 ' C ' HG12 ' A' ' 136' ' ' VAL . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 142' ' ' GLU . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 141' ' ' ILE . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 156' ' ' VAL . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 148' ' ' VAL . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.452 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 104' ' ' LEU . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.425 ' HE3' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.485 1.32 0 CA-C-O 120.948 0.404 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.874 HD12 HG22 ' A' ' 162' ' ' VAL . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.414 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.711 HD13 ' CE1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.511 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.51 HD11 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.51 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 136' ' ' VAL . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.469 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.874 HG22 HD12 ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p . . . . . 0 N--CA 1.484 1.226 0 CA-C-O 120.708 0.289 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 162' ' ' VAL . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.533 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.466 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.622 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.622 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.466 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.692 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.789 ' SD ' HD11 ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 131' ' ' LEU . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 130' ' ' LYS . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.789 HD11 ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 139' ' ' ARG . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 124' ' ' LEU . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' ND2' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.786 HD22 ' H ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.786 ' H ' HD22 ' A' ' 151' ' ' ASN . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.523 HG22 HG11 ' A' ' 148' ' ' VAL . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.507 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.63 ' O ' HG23 ' A' ' 162' ' ' VAL . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 104' ' ' LEU . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.483 1.209 0 CA-C-O 121.009 0.433 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 111' ' ' PHE . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.563 ' HG3' HG22 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.611 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 m-70 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 128' ' ' MET . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.897 ' H ' HG13 ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.638 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.668 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.729 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.46 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.499 ' HG2' HH11 ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 CA-C-O 121.187 0.517 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.714 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.854 ' ND2' ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.714 HD13 ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.534 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.837 HD21 ' SD ' ' A' ' 128' ' ' MET . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 136' ' ' VAL . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.55 ' N ' ' CD2' ' A' ' 138' ' ' HIS . 10.0 m170 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 144' ' ' ILE . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.665 HG11 ' CG2' ' A' ' 156' ' ' VAL . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.665 ' CG2' HG11 ' A' ' 148' ' ' VAL . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.611 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m . . . . . 0 C--O 1.206 -1.213 0 CA-C-O 120.66 0.267 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 162' ' ' VAL . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 115' ' ' GLY . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 116' ' ' ASP . 0.3 OUTLIER -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.74 ' N ' ' ND2' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.764 ' N ' ' ND2' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 131' ' ' LEU . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.809 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . 0.531 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.531 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.55 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 162' ' ' VAL . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.805 HG22 HD12 ' A' ' 104' ' ' LEU . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 121.252 0.549 . . . . 0.0 110.724 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.643 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.643 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 124' ' ' LEU . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 124' ' ' LEU . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.461 ' OE1' ' OD1' ' A' ' 112' ' ' ASP . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.596 ' CB ' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.4 ' C ' ' N ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.464 ' NE2' HG22 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 124' ' ' LEU . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 120' ' ' SER . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.406 HG22 ' HG ' ' A' ' 104' ' ' LEU . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.832 0.348 . . . . 0.0 110.872 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -148.96 131.07 15.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.814 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.53 -173.37 3.94 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.82 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.477 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.6 mp -45.38 151.51 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.824 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.409 ' N ' ' CG2' ' A' ' 99' ' ' ILE . . . 146.08 -83.43 0.19 Allowed Glycine 0 N--CA 1.49 2.24 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.153 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 85.2 t -87.11 -16.08 9.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.623 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 41.3 tttt -60.76 -46.16 91.54 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 118.774 -1.171 . . . . 0.0 110.078 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' OE1' ' C ' ' A' ' 103' ' ' GLU . 1.3 tm-20 -45.99 -45.18 15.64 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 118.748 -1.181 . . . . 0.0 108.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.713 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -52.96 -41.18 64.29 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 179.762 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.4 ttm-85 -55.44 -40.38 71.46 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 119.12 -1.032 . . . . 0.0 109.223 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -49.95 -54.08 22.14 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 118.907 -1.117 . . . . 0.0 108.76 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.72 -56.7 18.17 Favored 'General case' 0 C--N 1.307 -1.249 0 C-N-CA 118.616 -1.234 . . . . 0.0 108.253 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.651 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 4.8 t80 -43.72 -33.48 1.26 Allowed 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.481 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' HH11 ' A' ' 109' ' ' ARG . 49.9 ttt-85 -68.84 -58.2 4.5 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.834 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -54.58 -30.0 53.12 Favored 'General case' 0 C--N 1.308 -1.2 0 C-N-CA 119.188 -1.005 . . . . 0.0 109.299 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' ' CB ' ' A' ' 127' ' ' ALA . 0.2 OUTLIER -57.31 -59.31 5.31 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.196 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.708 ' OD1' 'CA ' ' A' ' 501' ' ' ' CA' . 8.1 t70 -75.7 93.54 3.11 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.711 -0.796 . . . . 0.0 110.893 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.09 -25.75 67.89 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.684 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -94.6 -95.73 0.17 Allowed 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.837 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.621 ' N ' ' OD2' ' A' ' 112' ' ' ASP . . . 173.24 78.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.276 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.549 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.479 ' CG ' ' OD1' ' A' ' 112' ' ' ASP . 1.6 p30 -142.23 -3.52 1.07 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.646 -0.821 . . . . 0.0 110.539 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.28 34.37 62.92 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.575 -1.298 . . . . 0.0 110.52 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -150.36 118.58 6.37 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.782 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.438 HG12 ' CD1' ' A' ' 111' ' ' PHE . 24.1 mt -89.13 112.5 24.3 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.948 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.508 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 54.8 p -101.47 161.14 13.85 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.992 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -39.24 -41.0 0.82 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.535 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 2.2 m -66.04 -47.06 75.63 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.186 -1.005 . . . . 0.0 109.407 179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.508 ' HB2' ' H ' ' A' ' 120' ' ' SER . 44.3 mt-10 -70.9 -38.25 72.99 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 119.417 -0.913 . . . . 0.0 109.634 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.508 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -56.26 -62.5 1.67 Allowed 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.01 -1.076 . . . . 0.0 109.373 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.2 ttt180 -43.43 -46.49 6.71 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.021 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -59.73 -35.67 75.02 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.564 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -71.04 -57.85 4.13 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 119.331 -0.947 . . . . 0.0 109.511 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 3.3 mmt -56.33 -31.49 63.78 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 118.838 -1.145 . . . . 0.0 110.364 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 8.4 ttt180 -62.72 -45.69 91.57 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.431 -0.908 . . . . 0.0 111.441 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -59.28 -30.6 68.43 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.098 -1.041 . . . . 0.0 111.071 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.2 mp -91.54 -47.92 7.15 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.017 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.9 mp -88.06 -73.4 0.49 Allowed 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.638 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 73.21 148.97 1.1 Allowed Glycine 0 N--CA 1.491 2.308 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.494 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 63.81 -175.82 0.16 Allowed 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.454 ' HG2' ' H ' ' A' ' 136' ' ' VAL . 5.0 tt0 65.2 168.98 0.19 Allowed 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.837 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' H ' ' HG2' ' A' ' 135' ' ' GLN . 2.3 m -119.76 -164.23 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.747 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 96.59 76.29 1.3 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.795 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -87.99 -34.02 18.2 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.256 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.429 ' HG3' ' N ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -54.7 -32.59 59.69 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.389 -0.925 . . . . 0.0 110.15 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.491 ' O ' HD13 ' A' ' 144' ' ' ILE . 11.3 t70 -64.66 -35.43 81.0 Favored 'General case' 0 C--N 1.308 -1.204 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.263 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mt -62.21 -56.58 16.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 C-N-CA 119.324 -0.95 . . . . 0.0 110.181 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -62.34 -33.19 74.22 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.982 -1.087 . . . . 0.0 109.765 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 18.9 tp10 -60.72 -38.42 85.03 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.317 -0.953 . . . . 0.0 109.875 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.491 HD13 ' O ' ' A' ' 140' ' ' ASP . 1.3 mp -68.44 -36.46 74.94 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.957 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.509 ' O ' HG22 ' A' ' 145' ' ' ILE . 30.3 mt -80.47 -12.31 12.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.211 0 C-N-CA 119.224 -0.99 . . . . 0.0 110.324 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.642 ' O ' HD21 ' A' ' 150' ' ' LEU . 35.7 ttm180 -90.61 -34.43 15.47 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 119.534 -0.867 . . . . 0.0 110.892 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -90.64 -9.92 45.14 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.607 -0.837 . . . . 0.0 111.798 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.946 HG13 ' H ' ' A' ' 149' ' ' ASP . 2.6 p -54.6 -65.05 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.874 -1.13 . . . . 0.0 111.278 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.946 ' H ' HG13 ' A' ' 148' ' ' VAL . 0.0 OUTLIER 177.1 -39.07 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.888 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.769 HD23 ' H ' ' A' ' 149' ' ' ASP . 0.4 OUTLIER 23.94 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.184 0.928 . . . . 0.0 112.684 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -52.26 -4.39 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.504 179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.598 ' H ' ' C ' ' A' ' 150' ' ' LEU . . . 144.21 3.98 0.72 Allowed Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.577 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.54 5.16 39.22 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.465 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 43.8 29.94 1.49 Allowed Glycine 0 N--CA 1.492 2.395 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.492 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -148.34 161.87 40.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.511 -0.875 . . . . 0.0 110.9 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 53.0 t -93.44 137.21 23.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 119.176 -1.01 . . . . 0.0 112.52 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 5.8 p30 -127.75 162.43 26.62 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.806 -1.088 . . . . 0.0 108.441 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.651 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 11.7 t80 -37.86 -25.25 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.97 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.537 ' N ' ' O ' ' A' ' 157' ' ' ASP . 18.5 tp10 -80.19 -60.56 2.28 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.246 -0.982 . . . . 0.0 109.302 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.594 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 3.0 mp0 -60.64 -26.51 67.09 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 119.366 -0.934 . . . . 0.0 109.347 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.713 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.4 t80 -73.38 -37.59 65.95 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.716 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.5 t -69.13 -30.27 45.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.554 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.6 -18.53 37.91 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.39 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.0 ttm -88.05 -23.02 23.88 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.858 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 30.2 tpp -80.72 -49.38 11.26 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 119.035 -1.066 . . . . 0.0 111.135 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 6.4 t -49.55 166.69 0.05 Allowed 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.827 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.3 ttp85 . . . . . 0 C--N 1.306 -1.305 0 CA-C-O 116.314 -1.803 . . . . 0.0 110.832 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . 0.708 'CA ' ' OD1' ' A' ' 112' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.465 ' C ' ' CG ' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.483 1.183 0 CA-C-O 120.758 0.313 . . . . 0.0 110.852 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.465 ' CG ' ' C ' ' A' ' 96' ' ' ALA . 0.3 OUTLIER 68.09 129.92 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 119.468 -0.893 . . . . 0.0 110.72 -179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.3 ttt -68.49 83.82 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.295 -0.962 . . . . 0.0 110.817 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.758 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.3 pp -60.32 -165.96 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 C-N-CA 119.519 -0.873 . . . . 0.0 110.917 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -152.36 160.49 28.96 Favored Glycine 0 N--CA 1.492 2.385 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.692 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 11.1 t -68.08 -9.96 11.87 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' O ' ' N ' ' A' ' 105' ' ' ARG . 7.7 mmmt -54.85 -40.47 69.67 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.514 -1.274 . . . . 0.0 110.19 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.439 ' O ' ' N ' ' A' ' 106' ' ' ASP . 86.0 tt0 -46.77 -49.74 19.31 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 118.585 -1.246 . . . . 0.0 108.466 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.735 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.55 -43.49 46.01 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' N ' ' O ' ' A' ' 102' ' ' LYS . 8.2 ttt85 -53.06 -40.37 63.96 Favored 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 119.378 -0.929 . . . . 0.0 108.705 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' A' ' 103' ' ' GLU . 3.5 t70 -47.82 -52.41 19.08 Favored 'General case' 0 C--N 1.311 -1.079 0 C-N-CA 118.975 -1.09 . . . . 0.0 108.711 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -60.13 -49.09 79.0 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 118.87 -1.132 . . . . 0.0 108.82 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 2.4 t80 -48.99 -38.52 23.46 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.934 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 11.2 tpp85 -64.81 -57.36 9.08 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -55.95 -29.05 59.56 Favored 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.296 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.519 ' CD2' HD11 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -60.48 -60.94 3.01 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.986 -1.007 . . . . 0.0 110.332 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -86.08 132.48 34.03 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.167 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -114.16 5.58 15.99 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.309 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -118.16 -149.22 0.44 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.871 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -122.45 33.68 4.06 Favored Glycine 0 N--CA 1.498 2.83 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 4.4 m-20 -85.5 -30.25 23.6 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.703 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.66 -2.99 87.64 Favored Glycine 0 N--CA 1.492 2.422 0 C-N-CA 119.504 -1.331 . . . . 0.0 110.875 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 20.9 mt-10 -146.58 155.06 42.21 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.334 -0.947 . . . . 0.0 111.035 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.519 HD11 ' CD2' ' A' ' 111' ' ' PHE . 15.2 mt -89.54 115.76 29.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.309 0 C-N-CA 119.27 -0.972 . . . . 0.0 110.379 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.45 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 33.2 t -96.28 160.57 14.35 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.747 -0.781 . . . . 0.0 111.23 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.421 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.3 OUTLIER -38.65 -53.23 1.64 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.94 -0.704 . . . . 0.0 111.122 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 1.1 t -61.41 -46.24 90.95 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.291 -0.964 . . . . 0.0 110.563 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.45 ' HB2' ' H ' ' A' ' 120' ' ' SER . 51.5 mt-10 -68.63 -34.31 75.52 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.181 -1.007 . . . . 0.0 110.599 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.69 HD23 ' CD1' ' A' ' 145' ' ' ILE . 0.9 OUTLIER -66.92 -61.98 1.67 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 118.528 -1.269 . . . . 0.0 109.116 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 124' ' ' LEU . 21.5 ttt180 -43.05 -38.15 2.21 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.559 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -60.87 -52.82 63.45 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.177 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -67.96 -29.52 68.58 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.358 -0.937 . . . . 0.0 110.224 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.06 -28.9 61.63 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 119.486 -0.886 . . . . 0.0 110.291 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 -71.08 -43.13 68.37 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.543 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.4 ttmp? -52.76 -25.97 12.82 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.684 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.559 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.8 mp -91.2 -44.86 8.98 Favored 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.572 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.7 mt -81.99 -147.79 0.07 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.58 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -172.66 -13.75 0.02 OUTLIER Glycine 0 N--CA 1.491 2.324 0 C-N-CA 119.299 -1.429 . . . . 0.0 110.571 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.498 ' O ' ' N ' ' A' ' 136' ' ' VAL . 92.7 m-70 -94.46 79.41 3.87 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 119.493 -0.883 . . . . 0.0 110.966 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -63.21 76.32 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.712 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.498 ' N ' ' O ' ' A' ' 134' ' ' HIS . 90.3 t -149.77 136.68 13.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.366 -0.934 . . . . 0.0 110.936 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 75.0 108.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.333 0 C-N-CA 119.441 -1.361 . . . . 0.0 110.648 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.452 ' CE1' ' HG3' ' A' ' 142' ' ' GLU . 11.9 t-80 -89.88 -14.86 33.38 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.478 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -52.2 -39.85 60.74 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.606 -0.838 . . . . 0.0 110.592 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -49.53 -70.52 0.09 Allowed 'General case' 0 C--N 1.305 -1.328 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.273 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 43.4 mm -46.16 -60.67 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.391 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HG3' ' CE1' ' A' ' 138' ' ' HIS . 30.2 mt-10 -46.63 -47.78 19.99 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.762 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -48.2 -48.6 34.67 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.305 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.452 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -64.9 -44.75 96.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 C-N-CA 119.145 -1.022 . . . . 0.0 110.068 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.69 ' CD1' HD23 ' A' ' 124' ' ' LEU . 2.0 mm -62.16 -23.07 30.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.862 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.534 ' O ' ' N ' ' A' ' 148' ' ' VAL . 3.8 mmp_? -90.74 -69.08 0.75 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.411 -0.916 . . . . 0.0 111.826 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -45.65 -12.45 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.813 -0.755 . . . . 0.0 111.918 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.697 HG11 HG22 ' A' ' 156' ' ' VAL . 6.1 p -95.36 -25.01 4.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 C-N-CA 119.397 -0.921 . . . . 0.0 111.205 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.614 ' OD2' ' N ' ' A' ' 154' ' ' GLY . 11.4 t0 -61.47 124.78 21.6 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.353 -0.939 . . . . 0.0 111.37 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 44.1 mt -99.75 -19.96 16.48 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 119.796 -0.761 . . . . 0.0 110.536 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.417 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -104.24 -60.44 1.58 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.959 -0.696 . . . . 0.0 110.864 -179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 146.4 14.58 0.17 Allowed Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.563 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.507 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 0.0 OUTLIER -72.69 -52.03 16.92 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.24 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.614 ' N ' ' OD2' ' A' ' 149' ' ' ASP . . . 111.2 28.55 3.79 Favored Glycine 0 N--CA 1.496 2.667 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.17 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.48 ' N ' ' OD2' ' A' ' 153' ' ' ASP . 0.3 OUTLIER -150.32 161.11 43.1 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.064 -1.054 . . . . 0.0 111.297 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.697 HG22 HG11 ' A' ' 148' ' ' VAL . 15.8 t -95.56 131.09 43.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 115.36 -0.837 . . . . 0.0 111.964 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 37.4 t70 -111.6 160.13 17.5 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.262 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.595 ' O ' HG23 ' A' ' 162' ' ' VAL . 27.4 t80 -37.99 -56.14 1.17 Allowed 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.443 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.6 mm-40 -59.81 -57.28 13.57 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.891 -1.124 . . . . 0.0 110.368 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.576 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 25.9 mt-10 -57.36 -29.97 64.47 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.555 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.735 ' CE2' HD12 ' A' ' 104' ' ' LEU . 0.6 OUTLIER -74.7 -36.06 62.74 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.073 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 158' ' ' PHE . 70.8 t -72.85 -34.26 46.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.37 -0.932 . . . . 0.0 110.383 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.2 mtt180 -75.89 -26.96 57.52 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.206 -0.998 . . . . 0.0 110.241 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.509 ' O ' ' SD ' ' A' ' 164' ' ' MET . 6.4 tpp -72.57 -34.8 67.71 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.201 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 3.5 mmt -58.23 -34.83 70.86 Favored 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.751 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.605 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 32.9 t -71.47 -127.44 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.72 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.605 ' N ' ' OG ' ' A' ' 166' ' ' SER . 26.3 ttm180 . . . . . 0 C--N 1.306 -1.318 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.749 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.15 0 CA-C-O 120.804 0.335 . . . . 0.0 110.839 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 44.9 p-10 -89.86 154.15 20.1 Favored 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.379 -0.928 . . . . 0.0 111.031 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 2.3 tpt -66.41 121.8 16.1 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.494 -0.882 . . . . 0.0 110.599 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.683 HD13 ' N ' ' A' ' 99' ' ' ILE . 0.1 OUTLIER -60.67 -169.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 C-N-CA 119.047 -1.061 . . . . 0.0 110.326 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.49 ' O ' ' N ' ' A' ' 102' ' ' LYS . . . 147.65 -50.69 0.58 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.145 -1.502 . . . . 0.0 110.621 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' GLY . 4.2 p -41.65 -23.93 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.768 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.2 OUTLIER -48.75 -33.98 11.31 Favored 'General case' 0 C--N 1.301 -1.53 0 C-N-CA 118.489 -1.285 . . . . 0.0 109.216 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.635 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 8.8 pt-20 -48.11 -46.01 33.57 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 118.557 -1.257 . . . . 0.0 107.612 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.684 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -54.44 -41.42 69.39 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 107.217 -1.401 . . . . 0.0 107.217 179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 102' ' ' LYS . 7.0 ttt85 -59.61 -37.42 78.55 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.045 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -50.21 -49.91 51.19 Favored 'General case' 0 C--N 1.313 -0.982 0 C-N-CA 118.881 -1.128 . . . . 0.0 108.559 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.76 -54.91 40.81 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.809 -1.157 . . . . 0.0 108.165 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -40.45 -40.64 1.25 Allowed 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.004 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.1 mmm180 -64.08 -62.96 1.29 Allowed 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 118.924 -1.11 . . . . 0.0 110.074 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -51.13 -25.45 5.22 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 118.528 -1.269 . . . . 0.0 108.73 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.802 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -68.85 -50.64 48.18 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.524 -1.216 . . . . 0.0 109.993 179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -116.13 102.08 9.29 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.691 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.444 ' H ' HG23 ' A' ' 113' ' ' THR . 44.7 p -63.86 -44.78 92.08 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.678 -0.809 . . . . 0.0 110.967 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -48.32 -39.96 23.62 Favored 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.542 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 83.44 34.28 20.33 Favored Glycine 0 N--CA 1.484 1.865 0 C-N-CA 119.344 -1.408 . . . . 0.0 110.095 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.17 -72.28 0.33 Allowed 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.38 -0.928 . . . . 0.0 110.769 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 167.85 -13.27 0.06 OUTLIER Glycine 0 N--CA 1.491 2.309 0 C-N-CA 119.436 -1.364 . . . . 0.0 110.591 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.664 ' N ' ' CD ' ' A' ' 118' ' ' GLU . 1.0 OUTLIER -148.51 145.12 27.77 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.882 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.802 HD13 ' CD1' ' A' ' 111' ' ' PHE . 2.2 mt -99.23 148.61 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 C-N-CA 119.502 -0.879 . . . . 0.0 111.732 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 121' ' ' THR . 12.4 p -120.76 161.03 22.16 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.452 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.404 ' C ' ' O ' ' A' ' 120' ' ' SER . 38.0 p -39.9 -65.4 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.714 -0.795 . . . . 0.0 111.25 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 t -45.14 -57.47 3.89 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.197 -1.001 . . . . 0.0 110.528 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.36 -43.27 92.84 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.856 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.818 HD11 ' SD ' ' A' ' 128' ' ' MET . 14.1 tp -65.26 -46.61 79.82 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.929 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 ttt-85 -45.98 -38.47 7.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.69 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -73.04 -30.86 64.04 Favored 'General case' 0 C--N 1.31 -1.145 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.879 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.548 ' HB3' HD12 ' A' ' 124' ' ' LEU . . . -77.43 -24.8 50.3 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.72 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.818 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -81.46 -30.26 33.45 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.261 -0.976 . . . . 0.0 110.676 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 40.4 ttp85 -78.46 -35.05 47.27 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.934 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.455 ' NZ ' ' HB2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER -63.93 -15.15 58.45 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.596 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.5 mp -109.28 -45.75 3.68 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 120.033 -0.667 . . . . 0.0 110.568 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 65.5 mt -94.74 -128.16 0.13 Allowed 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.637 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 136.59 -4.24 3.65 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 119.725 -1.226 . . . . 0.0 110.572 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -94.63 -67.48 0.85 Allowed 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.811 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -77.97 162.96 26.39 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.326 -0.949 . . . . 0.0 110.695 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 16.4 m -147.84 19.47 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -49.19 129.59 23.87 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 119.313 -1.422 . . . . 0.0 110.536 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.591 ' ND1' ' N ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -84.82 -59.92 2.21 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.792 179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 38.4 ttt-85 -53.25 -16.95 1.44 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.679 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.15 -69.58 0.3 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.398 -0.921 . . . . 0.0 111.539 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.4 pt -58.31 -43.56 86.41 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.799 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -56.96 -54.73 43.31 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.266 -0.974 . . . . 0.0 111.059 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.8 tp10 -51.31 -37.98 50.51 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.761 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 5.2 mm -68.36 -29.64 44.91 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 C-N-CA 119.18 -1.008 . . . . 0.0 110.747 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.0 mt -86.7 -25.99 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.247 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.133 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -89.25 -29.99 18.83 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.461 -0.895 . . . . 0.0 111.032 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.406 ' O ' ' C ' ' A' ' 148' ' ' VAL . 28.5 t70 -78.68 -55.99 4.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.241 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.584 HG11 HG22 ' A' ' 156' ' ' VAL . 4.1 p -42.13 -42.27 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.918 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.578 ' N ' ' CG1' ' A' ' 148' ' ' VAL . 27.1 t70 -44.79 140.56 2.48 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.367 -0.933 . . . . 0.0 110.715 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.438 ' H ' HD12 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -141.14 11.82 2.18 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.806 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.43 ' ND2' ' CD1' ' A' ' 150' ' ' LEU . 0.5 OUTLIER -107.04 -53.38 2.62 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.876 -0.729 . . . . 0.0 110.672 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 153.27 4.46 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.264 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.21 -149.56 0.3 Allowed 'General case' 0 C--N 1.307 -1.24 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.562 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -146.66 29.66 1.57 Allowed Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.122 -1.513 . . . . 0.0 110.798 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.3 mtm-85 -141.87 161.16 38.67 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 119.838 -0.745 . . . . 0.0 110.757 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.584 HG22 HG11 ' A' ' 148' ' ' VAL . 2.4 t -94.75 142.16 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 C-N-CA 119.43 -0.908 . . . . 0.0 111.55 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -115.51 160.09 20.39 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.315 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -45.8 -27.45 0.85 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.166 -1.014 . . . . 0.0 110.408 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -75.75 -61.17 2.01 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.125 -1.03 . . . . 0.0 109.656 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -59.76 -31.74 69.93 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.075 -1.05 . . . . 0.0 109.463 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.684 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 22.9 t80 -63.16 -48.23 79.31 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.754 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.59 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.57 -27.27 27.94 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.502 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -79.32 -29.51 42.37 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.234 -0.986 . . . . 0.0 110.415 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.4 tpt -69.35 -36.29 76.74 Favored 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.629 -1.229 . . . . 0.0 109.854 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 18.5 mmt -58.27 -30.85 66.92 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 119.007 -1.077 . . . . 0.0 110.289 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 70.4 m -101.67 -131.07 0.25 Allowed 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.882 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 30.6 ttm180 . . . . . 0 C--N 1.307 -1.263 0 CA-C-O 116.325 -1.798 . . . . 0.0 110.838 179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 120.837 0.351 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -78.16 147.3 34.59 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.838 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.6 tpp -170.04 10.75 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.836 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.457 HG23 ' O ' ' A' ' 99' ' ' ILE . 4.0 tp -44.93 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.739 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.464 ' O ' ' N ' ' A' ' 102' ' ' LYS . . . 170.42 100.25 0.13 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.288 -1.434 . . . . 0.0 110.492 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.1 m -48.95 -12.97 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.828 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.9 mmtt -56.1 -44.04 78.66 Favored 'General case' 0 C--N 1.299 -1.615 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.544 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 102' ' ' LYS . 33.0 tt0 -45.05 -51.18 10.35 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.07 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.608 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.8 OUTLIER -51.88 -39.36 58.89 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.899 -1.12 . . . . 0.0 107.983 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 102' ' ' LYS . 2.4 ttt85 -54.88 -38.52 67.63 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.063 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -53.07 -55.32 24.76 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 118.993 -1.083 . . . . 0.0 108.748 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.1 -50.92 72.21 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 118.44 -1.304 . . . . 0.0 108.329 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.541 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.0 OUTLIER -44.51 -33.82 1.88 Allowed 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.054 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -66.19 -58.42 5.44 Favored 'General case' 0 C--N 1.309 -1.165 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.036 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -57.07 -26.54 60.55 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.093 -1.043 . . . . 0.0 109.864 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.46 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -61.28 -64.94 0.78 Allowed 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.077 179.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 114' ' ' ASN . 2.5 m-20 -71.92 74.7 0.89 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.895 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.501 HG23 HD22 ' A' ' 114' ' ' ASN . 0.0 OUTLIER -47.01 -15.35 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.695 179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.501 HD22 HG23 ' A' ' 113' ' ' THR . 0.1 OUTLIER -101.64 -89.88 0.35 Allowed 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.887 -0.725 . . . . 0.0 110.983 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 164.1 44.76 0.02 OUTLIER Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.541 -1.314 . . . . 0.0 109.86 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -86.77 -30.24 21.72 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.786 -0.765 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 93.9 1.3 65.52 Favored Glycine 0 N--CA 1.488 2.135 0 C-N-CA 119.346 -1.407 . . . . 0.0 109.896 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -150.61 142.39 23.75 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 119.64 -0.824 . . . . 0.0 110.757 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.46 HD13 ' CE1' ' A' ' 111' ' ' PHE . 33.0 mt -93.37 106.02 17.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.219 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.545 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 124' ' ' LEU . 4.1 m -97.04 161.45 13.82 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 119.899 -0.72 . . . . 0.0 111.373 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.433 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -38.4 -62.58 0.57 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.867 -0.733 . . . . 0.0 110.871 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 25.6 t -50.06 -54.43 20.39 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.981 -1.087 . . . . 0.0 109.652 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -57.08 -35.04 68.91 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.086 -1.045 . . . . 0.0 109.888 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.517 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -57.03 -59.94 4.33 Favored 'General case' 0 C--N 1.312 -1.029 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.604 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -42.68 -47.38 5.32 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.344 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 46.0 mm-40 -62.15 -41.19 98.04 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 118.759 -1.176 . . . . 0.0 109.403 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -69.26 -52.52 26.76 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.777 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.485 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.316 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 27.5 ttm180 -67.59 -32.9 73.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 119.014 -1.075 . . . . 0.0 110.915 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? -69.71 -46.17 66.56 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.364 -0.934 . . . . 0.0 111.408 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.654 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -72.77 -49.98 27.3 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.303 -0.959 . . . . 0.0 111.057 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -142.74 -163.87 1.71 Allowed 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.8 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -136.52 -178.05 15.49 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.228 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -145.02 158.08 43.92 Favored 'General case' 0 C--N 1.303 -1.419 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.581 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.626 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 10.6 mp0 -85.22 -127.89 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.762 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.82 94.87 4.09 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.664 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 160.61 105.21 0.2 Allowed Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.268 -1.444 . . . . 0.0 110.667 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.721 ' CD2' ' H ' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -89.08 -31.58 17.96 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.354 179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 82.7 mtt-85 -49.33 -21.5 0.87 Allowed 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.183 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.407 ' N ' ' C ' ' A' ' 138' ' ' HIS . 29.0 t70 -64.93 -53.75 41.56 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.399 -0.92 . . . . 0.0 110.163 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 8.7 mt -55.84 -46.6 80.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 118.968 -1.093 . . . . 0.0 110.019 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.42 -37.77 84.7 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 118.984 -1.086 . . . . 0.0 110.016 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -54.83 -38.04 66.92 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.174 -1.01 . . . . 0.0 109.809 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 18.7 mt -66.86 -44.83 88.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 C-N-CA 119.303 -0.959 . . . . 0.0 109.996 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 124' ' ' LEU . 23.7 mt -69.38 -12.4 15.99 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.058 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 46.9 ttp85 -88.51 -55.25 3.8 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.777 -0.769 . . . . 0.0 110.755 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -45.18 -38.4 5.28 Favored 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.796 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.916 HG13 ' N ' ' A' ' 149' ' ' ASP . 9.2 p -68.43 -124.5 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.41 -0.916 . . . . 0.0 110.658 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.916 ' N ' HG13 ' A' ' 148' ' ' VAL . 25.1 t70 52.47 89.13 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.535 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.463 ' H ' ' HG2' ' A' ' 160' ' ' GLU . 8.0 mp -79.89 -27.86 39.93 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.9 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.589 ' ND2' ' OE2' ' A' ' 160' ' ' GLU . 1.6 p30 -90.67 -91.04 0.15 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.408 -0.917 . . . . 0.0 111.057 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 179.65 31.18 0.06 OUTLIER Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.356 -1.402 . . . . 0.0 110.418 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -90.81 -69.07 0.75 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.518 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.98 -42.54 1.18 Allowed Glycine 0 N--CA 1.493 2.493 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.946 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 1.4 mpp_? -89.98 162.95 15.14 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.213 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.449 HG22 HG11 ' A' ' 148' ' ' VAL . 61.4 t -88.91 140.8 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.385 -0.926 . . . . 0.0 112.133 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 158' ' ' PHE . 0.7 OUTLIER -134.66 159.77 40.21 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.419 179.916 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.541 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.9 t80 -38.96 -32.34 0.08 Allowed 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.65 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 159' ' ' GLU . 2.4 mp0 -71.89 -64.55 0.91 Allowed 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.917 -1.113 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.589 ' OE2' ' ND2' ' A' ' 151' ' ' ASN . 24.1 mt-10 -64.37 -23.48 67.31 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.219 -0.992 . . . . 0.0 110.334 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.608 ' CE2' HD12 ' A' ' 104' ' ' LEU . 9.0 t80 -75.32 -33.07 61.12 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.191 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 158' ' ' PHE . 6.6 t -72.81 -32.29 39.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.414 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 163' ' ' ARG . 5.5 tpt180 -84.27 -17.69 38.86 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.515 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.438 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 5.8 ttp -90.08 -18.39 25.99 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.356 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.43 ' O ' ' C ' ' A' ' 166' ' ' SER . 25.0 tpp -90.13 -79.84 0.33 Allowed 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 118.777 -1.169 . . . . 0.0 110.927 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.43 ' C ' ' O ' ' A' ' 165' ' ' MET . 5.9 t 35.86 80.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.564 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.4 ttp85 . . . . . 0 C--N 1.307 -1.271 0 CA-C-O 116.315 -1.803 . . . . 0.0 110.851 179.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -147.42 -50.89 0.19 Allowed 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.675 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 53.1 mtt -49.12 -21.21 0.69 Allowed 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.744 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.414 HD13 HG21 ' A' ' 99' ' ' ILE . 6.5 mt -71.81 -51.15 33.67 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.769 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.486 ' O ' HD23 ' A' ' 104' ' ' LEU . . . 108.12 43.3 1.3 Allowed Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.879 -1.153 . . . . 0.0 110.83 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 102' ' ' LYS . 24.2 t -82.13 -70.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.222 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.424 ' N ' HG12 ' A' ' 101' ' ' VAL . 35.2 mmtt -62.01 -34.11 75.59 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 118.163 -1.415 . . . . 0.0 108.804 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 16.2 tp10 -57.67 -43.52 85.07 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.921 -1.112 . . . . 0.0 108.301 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.725 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.3 OUTLIER -51.52 -44.93 62.75 Favored 'General case' 0 C--N 1.31 -1.128 0 C-N-CA 118.376 -1.33 . . . . 0.0 107.698 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -50.25 -40.73 48.74 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.397 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.613 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.7 OUTLIER -51.45 -53.92 32.2 Favored 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.181 179.96 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.97 -50.81 68.01 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.484 -1.286 . . . . 0.0 108.464 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.533 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.6 OUTLIER -41.63 -39.48 1.65 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.353 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.469 ' HG3' ' NH1' ' A' ' 109' ' ' ARG . 0.0 OUTLIER -63.14 -56.62 15.24 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.268 -0.973 . . . . 0.0 109.464 179.936 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -60.95 -33.38 73.09 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 118.911 -1.116 . . . . 0.0 109.18 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.518 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -56.97 -61.25 2.58 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 115.058 -0.974 . . . . 0.0 109.893 179.806 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -79.6 131.81 36.1 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.406 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.503 HG21 ' OE2' ' A' ' 126' ' ' GLU . 0.6 OUTLIER -85.12 -13.25 50.82 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.794 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.562 ' ND2' ' H ' ' A' ' 115' ' ' GLY . 2.8 p-10 -103.46 -80.04 0.53 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.69 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.562 ' H ' ' ND2' ' A' ' 114' ' ' ASN . . . 144.0 41.46 0.06 OUTLIER Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.483 -1.341 . . . . 0.0 110.396 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.47 ' N ' ' OD1' ' A' ' 116' ' ' ASP . 32.5 p-10 -90.63 -20.89 22.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.906 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 96.0 16.24 39.21 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.482 -1.342 . . . . 0.0 110.553 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.418 ' OE2' ' OD2' ' A' ' 157' ' ' ASP . 79.1 mt-10 -151.95 133.33 14.54 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.977 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.518 HD13 ' CE1' ' A' ' 111' ' ' PHE . 14.9 mt -88.77 113.98 26.35 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.166 -1.013 . . . . 0.0 109.719 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.484 ' CB ' ' NE ' ' A' ' 155' ' ' ARG . 67.8 m -89.86 158.41 17.47 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.476 -0.889 . . . . 0.0 111.835 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 1.3 m -44.44 -44.7 8.64 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.899 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.64 -56.96 13.01 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.363 -0.935 . . . . 0.0 109.745 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -57.26 -25.09 58.62 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.112 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.47 ' O ' ' N ' ' A' ' 127' ' ' ALA . 0.1 OUTLIER -66.47 -59.4 3.7 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 118.721 -1.192 . . . . 0.0 109.668 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -44.14 -45.1 8.08 Favored 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.491 -0.884 . . . . 0.0 110.068 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.503 ' OE2' HG21 ' A' ' 113' ' ' THR . 10.1 tt0 -66.1 -35.79 81.45 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 118.806 -1.157 . . . . 0.0 109.396 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.53 -51.29 17.53 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.369 -0.932 . . . . 0.0 109.649 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 6.5 mtt -63.75 -31.72 72.98 Favored 'General case' 0 C--N 1.311 -1.102 0 C-N-CA 119.049 -1.06 . . . . 0.0 110.174 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -64.17 -40.79 96.88 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.329 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 35.8 tttt -59.35 -41.63 89.69 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.28 -0.968 . . . . 0.0 110.751 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.9 mp -78.48 -51.32 10.16 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.871 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 19.0 mt -85.95 -146.64 0.11 Allowed 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.847 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 177.27 -17.06 0.04 OUTLIER Glycine 0 N--CA 1.49 2.246 0 C-N-CA 119.513 -1.327 . . . . 0.0 110.356 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -74.68 127.69 33.75 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.005 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.7 mm100 -66.57 138.0 57.17 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 119.193 -1.003 . . . . 0.0 110.207 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG12 ' N ' ' A' ' 137' ' ' GLY . 75.7 t -149.21 162.67 4.61 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 C-N-CA 119.153 -1.019 . . . . 0.0 111.204 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.561 ' N ' HG12 ' A' ' 136' ' ' VAL . . . -65.85 176.74 15.47 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.174 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.408 ' HB2' ' NH1' ' A' ' 139' ' ' ARG . 72.7 m80 -90.27 -34.44 15.76 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.144 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.408 ' NH1' ' HB2' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -52.69 -20.97 3.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.543 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -74.32 -61.7 1.77 Allowed 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.455 -0.898 . . . . 0.0 110.766 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.1 mt -56.06 -46.19 80.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.71 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 63.3 mt-10 -53.13 -47.99 68.25 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.43 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -51.08 -43.73 61.08 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 118.933 -1.107 . . . . 0.0 110.005 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 4.3 mt -69.9 -38.31 75.25 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 119.21 -0.996 . . . . 0.0 110.03 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.402 ' CG2' ' O ' ' A' ' 154' ' ' GLY . 1.6 mm -61.84 -29.34 46.11 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.124 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 30.3 mtt180 -85.19 -44.59 12.79 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 119.521 -0.872 . . . . 0.0 110.867 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -51.78 -30.26 22.26 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.496 -0.882 . . . . 0.0 111.179 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.716 HG11 HG22 ' A' ' 156' ' ' VAL . 0.8 OUTLIER -85.13 -22.95 7.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.832 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.588 ' CG ' ' H ' ' A' ' 150' ' ' LEU . 26.5 t70 -57.58 -176.25 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.916 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.588 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 5.8 tp -169.49 -38.33 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.065 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.6 HD21 ' CG ' ' A' ' 153' ' ' ASP . 13.7 p-10 -81.99 -64.2 1.23 Allowed 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.815 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.592 ' H ' ' CG ' ' A' ' 151' ' ' ASN . . . -170.64 -62.4 0.04 OUTLIER Glycine 0 N--CA 1.489 2.208 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.439 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.6 ' CG ' HD21 ' A' ' 151' ' ' ASN . 2.3 p30 -48.84 148.32 2.27 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.798 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.402 ' O ' ' CG2' ' A' ' 145' ' ' ILE . . . -93.94 66.61 1.59 Allowed Glycine 0 N--CA 1.486 1.968 0 C-N-CA 119.414 -1.374 . . . . 0.0 109.972 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.484 ' NE ' ' CB ' ' A' ' 120' ' ' SER . 41.7 mtt180 -150.76 160.87 43.57 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.716 HG22 HG11 ' A' ' 148' ' ' VAL . 1.8 t -97.04 150.42 4.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 C-N-CA 119.443 -0.903 . . . . 0.0 111.808 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.5 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 0.6 OUTLIER -132.58 159.89 38.2 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.271 179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.414 ' C ' ' O ' ' A' ' 157' ' ' ASP . 31.1 t80 -40.24 -43.19 1.64 Allowed 'General case' 0 N--CA 1.496 1.862 0 C-N-CA 119.186 -1.006 . . . . 0.0 111.359 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.462 ' C ' ' OE1' ' A' ' 159' ' ' GLU . 12.8 tm-20 -66.73 -58.8 4.36 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.011 -1.076 . . . . 0.0 110.324 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.487 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.8 mt-10 -62.67 -27.1 69.0 Favored 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 119.311 -0.955 . . . . 0.0 110.139 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.725 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.9 t80 -75.66 -46.1 33.34 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.39 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.475 HG22 ' HG ' ' A' ' 104' ' ' LEU . 2.5 t -61.86 -31.56 51.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 C-N-CA 119.164 -1.014 . . . . 0.0 110.003 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 13.6 tpp180 -79.0 -25.26 43.33 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.255 -0.978 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.1 tpt -76.42 -20.55 56.98 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 118.837 -1.145 . . . . 0.0 110.254 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 39.7 tpp -85.06 -17.38 37.59 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 119.009 -1.076 . . . . 0.0 110.977 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.68 -154.31 0.61 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 116.318 -1.801 . . . . 0.0 110.729 -179.978 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.902 0.382 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -80.06 81.44 6.32 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.867 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.94 112.7 3.05 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.568 -0.853 . . . . 0.0 110.657 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.69 -76.51 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.02 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 169.28 -15.5 0.06 OUTLIER Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.277 -1.44 . . . . 0.0 110.445 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 1.8 p -59.55 -24.97 30.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 119.509 -0.876 . . . . 0.0 110.812 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.519 ' O ' ' N ' ' A' ' 105' ' ' ARG . 2.0 mtpp -47.62 -39.89 18.1 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.432 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.631 ' CG ' ' N ' ' A' ' 104' ' ' LEU . 17.2 pt-20 -47.12 -45.98 22.7 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 118.575 -1.25 . . . . 0.0 108.362 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' N ' ' CG ' ' A' ' 103' ' ' GLU . 0.2 OUTLIER -55.17 -40.55 70.8 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 9.5 ttt85 -57.13 -35.05 69.03 Favored 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 119.173 -1.011 . . . . 0.0 108.827 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -52.71 -53.97 40.18 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 118.971 -1.092 . . . . 0.0 108.711 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -52.91 -55.41 23.55 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 118.738 -1.185 . . . . 0.0 108.623 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.42 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.5 OUTLIER -38.4 -33.95 0.12 Allowed 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.449 179.723 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.441 ' C ' ' N ' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -71.48 -58.75 3.22 Favored 'General case' 0 C--N 1.307 -1.271 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.268 179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -52.96 -18.38 1.94 Allowed 'General case' 0 C--N 1.31 -1.115 0 C-N-CA 119.047 -1.061 . . . . 0.0 108.572 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.801 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -76.17 -63.3 1.35 Allowed 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.429 -1.259 . . . . 0.0 109.905 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -98.47 93.81 6.37 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.206 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -80.79 -7.75 59.49 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.262 -0.975 . . . . 0.0 111.395 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.422 HD21 ' HB2' ' A' ' 116' ' ' ASP . 0.5 OUTLIER -83.56 -29.88 27.47 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.754 179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 85.8 77.74 1.2 Allowed Glycine 0 N--CA 1.491 2.355 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.442 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.422 ' HB2' HD21 ' A' ' 114' ' ' ASN . 5.3 t0 -123.13 -53.08 1.84 Allowed 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.673 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 142.79 -23.68 2.3 Favored Glycine 0 N--CA 1.491 2.322 0 C-N-CA 119.606 -1.283 . . . . 0.0 110.256 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -150.72 156.97 42.37 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.099 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.801 HD13 ' CD1' ' A' ' 111' ' ' PHE . 10.9 mt -89.24 110.32 21.4 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 C-N-CA 118.81 -1.156 . . . . 0.0 110.823 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 121' ' ' THR . 32.6 t -99.25 160.97 13.89 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.466 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.435 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.0 OUTLIER -34.74 -60.98 0.42 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.58 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -49.1 -57.5 6.52 Favored 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 118.65 -1.22 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -59.12 -38.62 80.05 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.736 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.428 ' O ' HD13 ' A' ' 124' ' ' LEU . 0.1 OUTLIER -53.85 -52.75 59.44 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 119.083 -1.047 . . . . 0.0 109.345 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.42 ' HE ' HG12 ' A' ' 141' ' ' ILE . 2.7 ttm180 -45.49 -52.74 9.87 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.136 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 17.2 tt0 -55.67 -50.53 70.0 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 118.901 -1.12 . . . . 0.0 108.917 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -59.29 -53.46 57.98 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.021 -1.072 . . . . 0.0 109.257 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.47 ' SD ' ' HB2' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -54.72 -46.19 74.19 Favored 'General case' 0 C--O 1.202 -1.416 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.054 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -45.24 -41.39 8.39 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 119.032 -1.067 . . . . 0.0 110.969 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.842 ' C ' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -66.85 -10.6 49.84 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.184 -1.006 . . . . 0.0 111.46 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.842 HD12 ' C ' ' A' ' 130' ' ' LYS . 9.9 mp -125.24 -43.07 1.96 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.988 -0.685 . . . . 0.0 111.034 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.47 ' HB2' ' SD ' ' A' ' 128' ' ' MET . 0.6 OUTLIER -101.16 137.49 39.45 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.118 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.5 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . -97.29 -149.53 25.51 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.68 -1.248 . . . . 0.0 110.663 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.488 ' O ' ' CB ' ' A' ' 135' ' ' GLN . 93.1 m-70 50.84 -89.68 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.901 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 133' ' ' GLY . 1.7 tt0 73.46 0.95 3.82 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.072 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.514 ' O ' HG12 ' A' ' 136' ' ' VAL . 63.2 t -58.16 -9.57 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.732 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . -139.19 112.73 0.87 Allowed Glycine 0 N--CA 1.495 2.613 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.311 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.413 ' CG ' HH11 ' A' ' 125' ' ' ARG . 10.5 m-70 -68.87 -9.34 50.99 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.117 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.73 -22.49 65.41 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.238 -0.985 . . . . 0.0 110.979 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -77.57 -68.29 0.64 Allowed 'General case' 0 C--N 1.305 -1.362 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.854 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.497 HG13 ' H ' ' A' ' 142' ' ' GLU . 1.8 pp -43.62 -42.1 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 C-N-CA 119.157 -1.017 . . . . 0.0 111.324 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.497 ' H ' HG13 ' A' ' 141' ' ' ILE . 52.3 mt-10 -66.22 -40.8 90.58 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 118.598 -1.241 . . . . 0.0 109.095 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' CD ' ' OD2' ' A' ' 147' ' ' ASP . 1.9 tm-20 -46.49 -44.41 17.58 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.937 -1.105 . . . . 0.0 109.133 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.482 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.6 mp -65.78 -37.15 79.24 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.328 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.416 ' N ' ' O ' ' A' ' 142' ' ' GLU . 0.1 OUTLIER -76.08 -19.85 15.37 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.7 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' N ' ' O ' ' A' ' 142' ' ' GLU . 9.3 tpt85 -86.16 -40.15 15.94 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.752 -0.779 . . . . 0.0 110.332 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.433 ' OD2' ' CD ' ' A' ' 143' ' ' GLU . 49.4 m-20 -62.1 -39.13 91.43 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.512 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.918 HG13 ' N ' ' A' ' 149' ' ' ASP . 5.7 p -75.54 -134.51 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.379 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.918 ' N ' HG13 ' A' ' 148' ' ' VAL . 4.9 m-20 46.74 83.54 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.739 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.65 -22.0 63.49 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.055 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.64 -150.75 0.16 Allowed 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.743 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -99.7 -17.42 25.99 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.686 -1.245 . . . . 0.0 110.347 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.465 ' OD2' ' OD1' ' A' ' 149' ' ' ASP . 3.9 p-10 -64.07 -160.61 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.777 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -149.07 42.28 0.82 Allowed Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.613 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.408 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.8 mtt180 -140.25 160.31 40.26 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 119.579 -0.848 . . . . 0.0 111.062 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.12 130.76 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 C-N-CA 119.672 -0.811 . . . . 0.0 111.389 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.23 160.32 20.59 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.477 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 26.8 t80 -48.51 -25.83 1.87 Allowed 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.771 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -75.56 -65.59 0.88 Allowed 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.922 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -57.54 -22.34 43.85 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 119.09 -1.044 . . . . 0.0 109.638 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.628 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 32.4 t80 -73.85 -55.59 6.01 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.779 -0.768 . . . . 0.0 109.58 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.8 t -56.52 -18.03 5.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.322 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.245 179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -83.25 -33.81 25.97 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.527 -0.869 . . . . 0.0 109.958 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 2.9 mtp -64.03 -24.04 67.56 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 118.348 -1.341 . . . . 0.0 109.307 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.564 ' HG2' HD21 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -82.92 -103.86 0.04 OUTLIER 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.596 179.98 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.9 p 41.01 21.83 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.661 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 165' ' ' MET . 15.2 ttm180 . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 116.354 -1.784 . . . . 0.0 110.813 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.171 0 CA-C-O 120.808 0.337 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.485 ' OD1' ' N ' ' A' ' 98' ' ' MET . 10.4 t70 -145.38 162.06 38.17 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 119.533 -0.867 . . . . 0.0 110.8 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.485 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 17.1 mtt -84.27 124.66 31.47 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.845 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 7.8 mm -65.87 153.27 8.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.449 -0.9 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.438 ' O ' ' CB ' ' A' ' 103' ' ' GLU . . . -92.79 -51.7 2.25 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.392 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.496 ' O ' ' N ' ' A' ' 104' ' ' LEU . 40.5 t -43.55 -70.21 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 119.414 -0.915 . . . . 0.0 110.686 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 101' ' ' VAL . 10.8 mttm -47.54 -32.03 4.93 Favored 'General case' 0 C--N 1.298 -1.666 0 C-N-CA 118.394 -1.322 . . . . 0.0 109.961 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.438 ' CB ' ' O ' ' A' ' 100' ' ' GLY . 6.2 tt0 -57.09 -35.38 69.33 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.169 -1.412 . . . . 0.0 108.244 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.621 HD12 HG22 ' A' ' 162' ' ' VAL . 37.6 mt -69.52 -39.03 77.79 Favored 'General case' 0 C--N 1.313 -1.013 0 C-N-CA 118.818 -1.153 . . . . 0.0 109.229 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -49.52 -34.34 17.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 117.986 -1.486 . . . . 0.0 107.12 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -62.78 -55.79 23.33 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.04 -57.08 9.57 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 107.386 -1.339 . . . . 0.0 107.386 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -40.28 -38.44 0.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.429 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' C ' ' N ' ' A' ' 111' ' ' PHE . 3.4 ttm180 -65.27 -64.23 0.91 Allowed 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.356 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -52.57 -17.51 1.3 Allowed 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 118.823 -1.151 . . . . 0.0 109.083 179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.761 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -77.34 -68.57 0.6 Allowed 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.595 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -63.34 145.75 54.92 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.115 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.6 -12.41 12.87 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.277 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -101.09 -128.42 0.21 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.823 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -153.24 26.88 0.79 Allowed Glycine 0 N--CA 1.491 2.307 0 C-N-CA 119.293 -1.432 . . . . 0.0 110.718 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.482 ' OD1' ' N ' ' A' ' 116' ' ' ASP . 14.3 p-10 -90.28 -43.04 10.63 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.316 -0.954 . . . . 0.0 111.1 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 108.36 28.69 4.52 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.688 -1.244 . . . . 0.0 110.287 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -150.68 140.2 21.54 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.15 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.761 HD13 ' CE1' ' A' ' 111' ' ' PHE . 11.6 mt -88.73 114.73 27.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 C-N-CA 118.664 -1.214 . . . . 0.0 111.364 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.449 ' O ' ' N ' ' A' ' 124' ' ' LEU . 96.3 p -95.93 161.28 14.06 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.279 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.4 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -36.94 -66.91 0.2 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.797 -0.761 . . . . 0.0 111.336 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.37 -57.52 3.98 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.412 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -58.62 -27.99 65.21 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.409 -0.916 . . . . 0.0 110.316 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.637 HD23 HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -63.5 -60.57 3.18 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 118.766 -1.174 . . . . 0.0 109.865 179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 50.1 ttt180 -43.04 -46.91 5.77 Favored 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.203 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.428 ' HA ' HH21 ' A' ' 129' ' ' ARG . 23.9 mm-40 -62.01 -36.69 82.29 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 118.726 -1.19 . . . . 0.0 109.666 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -72.75 -52.86 13.35 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.207 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 7.3 mtt -63.85 -15.77 59.69 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.949 -1.1 . . . . 0.0 110.911 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.428 HH21 ' HA ' ' A' ' 126' ' ' GLU . 0.0 OUTLIER -80.02 -42.97 22.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 119.035 -1.066 . . . . 0.0 110.702 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.5 mmtm -63.33 -16.12 59.4 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.814 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.441 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.2 mp -100.9 -49.17 4.22 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 119.741 -0.783 . . . . 0.0 110.839 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 42.5 mt -74.1 -94.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.765 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.428 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . 174.97 -37.68 0.11 Allowed Glycine 0 N--CA 1.489 2.184 0 C-N-CA 119.425 -1.369 . . . . 0.0 110.361 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.428 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 0.2 OUTLIER 174.84 94.2 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.389 -0.924 . . . . 0.0 110.804 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.733 ' H ' ' CD ' ' A' ' 135' ' ' GLN . 2.9 pm0 -72.18 158.28 36.19 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.385 -0.926 . . . . 0.0 110.576 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 136' ' ' VAL . 33.3 m -110.55 115.66 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.854 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 77.81 125.11 0.32 Allowed Glycine 0 N--CA 1.49 2.263 0 C-N-CA 119.43 -1.366 . . . . 0.0 110.5 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.562 ' CG ' ' N ' ' A' ' 139' ' ' ARG . 8.8 p80 -65.91 -45.85 80.44 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.854 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.562 ' N ' ' CG ' ' A' ' 138' ' ' HIS . 1.9 mtt-85 -42.24 -20.67 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.655 -0.818 . . . . 0.0 111.065 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 138' ' ' HIS . 0.8 OUTLIER -73.65 -70.63 0.36 Allowed 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.84 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.452 ' H ' HG23 ' A' ' 141' ' ' ILE . 1.2 pp -47.51 -18.34 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.919 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.471 ' N ' ' C ' ' A' ' 140' ' ' ASP . 3.6 mt-10 -74.16 -55.58 5.91 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.749 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -47.32 -38.06 12.07 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.22 -0.992 . . . . 0.0 109.973 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.29 -50.73 75.21 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.19 0 C-N-CA 118.979 -1.088 . . . . 0.0 110.002 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.637 HD11 HD23 ' A' ' 124' ' ' LEU . 0.7 OUTLIER -55.59 -23.21 13.97 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.283 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -82.73 -30.47 29.03 Favored 'General case' 0 C--N 1.305 -1.343 0 C-N-CA 119.371 -0.931 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.1 -39.09 19.95 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.139 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.662 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.2 p -67.47 -45.96 84.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 119.326 -0.95 . . . . 0.0 110.687 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.662 ' N ' HG13 ' A' ' 148' ' ' VAL . 58.7 t0 -50.53 107.67 0.18 Allowed 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.684 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.0 pp -75.62 -15.74 60.3 Favored 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.875 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.595 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -91.08 -64.4 1.13 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.411 -0.915 . . . . 0.0 110.617 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.595 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . 128.54 28.9 0.8 Allowed Glycine 0 N--CA 1.5 2.939 0 C-N-CA 119.83 -1.176 . . . . 0.0 110.532 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.528 ' N ' ' OD1' ' A' ' 151' ' ' ASN . 22.0 p30 -94.98 -10.34 31.26 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.543 -0.863 . . . . 0.0 110.682 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.451 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 77.94 24.63 63.9 Favored Glycine 0 N--CA 1.487 2.042 0 C-N-CA 119.514 -1.326 . . . . 0.0 110.254 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.503 ' N ' ' OD1' ' A' ' 153' ' ' ASP . 3.8 mtt180 -149.88 159.02 44.7 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.861 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 95.4 t -107.62 142.1 21.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.779 -0.769 . . . . 0.0 111.393 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.46 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 3.5 t0 -124.98 160.73 28.29 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.378 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.481 ' O ' HG23 ' A' ' 162' ' ' VAL . 5.4 t80 -40.94 -28.71 0.08 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.301 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' ASP . 0.9 OUTLIER -75.88 -66.29 0.8 Allowed 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.308 -0.957 . . . . 0.0 109.252 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 18.5 mt-10 -52.08 -28.48 17.65 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 118.817 -1.153 . . . . 0.0 108.61 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.9 t80 -65.89 -55.06 18.89 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.903 -1.044 . . . . 0.0 108.993 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.621 HG22 HD12 ' A' ' 104' ' ' LEU . 23.8 t -57.18 -21.9 15.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 CA-C-N 114.835 -1.075 . . . . 0.0 109.737 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 4.8 tpt180 -81.39 -29.11 34.09 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.214 -0.994 . . . . 0.0 110.482 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 3.4 ttm -72.56 -20.88 61.24 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 118.169 -1.412 . . . . 0.0 109.413 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.5 ' SD ' ' N ' ' A' ' 165' ' ' MET . 0.0 OUTLIER -87.99 -94.17 0.1 Allowed 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 118.723 -1.191 . . . . 0.0 110.622 -179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 p 39.8 32.67 0.11 Allowed 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 119.88 -0.728 . . . . 0.0 111.493 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.477 0 CA-C-O 116.328 -1.796 . . . . 0.0 110.87 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.206 0 CA-C-O 120.905 0.383 . . . . 0.0 110.693 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -89.74 97.64 11.31 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.878 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ttt -44.19 127.77 5.71 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.045 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' N ' HD12 ' A' ' 99' ' ' ILE . 1.7 mp -60.81 146.1 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 119.492 -0.883 . . . . 0.0 110.643 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 160.57 15.79 0.03 OUTLIER Glycine 0 N--CA 1.492 2.389 0 C-N-CA 119.23 -1.462 . . . . 0.0 110.872 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 95.1 t -44.68 -43.2 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.847 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 105' ' ' ARG . 0.1 OUTLIER -50.94 -47.27 61.11 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.878 -179.98 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -48.28 -47.28 36.47 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.965 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -51.19 -35.15 34.85 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.012 179.749 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.66 ' NH1' ' CG ' ' A' ' 158' ' ' PHE . 7.9 tpt180 -59.02 -45.26 91.14 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.077 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -48.21 -50.78 28.06 Favored 'General case' 0 C--N 1.312 -1.028 0 C-N-CA 118.507 -1.277 . . . . 0.0 108.929 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.43 -52.81 62.36 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 118.046 -1.462 . . . . 0.0 108.199 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.49 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -43.23 -34.08 1.08 Allowed 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.903 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.5 ttm-85 -62.49 -60.74 3.11 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.954 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -51.74 -33.93 37.02 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.361 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.653 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.4 OUTLIER -63.99 -66.82 0.49 Allowed 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.361 179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.429 ' OD1' ' OE1' ' A' ' 123' ' ' GLU . 3.2 t0 -80.59 108.83 14.56 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.103 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.04 -28.63 29.46 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.67 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.572 HD21 ' CD ' ' A' ' 123' ' ' GLU . 1.4 p30 -81.21 -40.57 23.64 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 119.201 -0.999 . . . . 0.0 110.528 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 98.79 65.81 0.86 Allowed Glycine 0 N--CA 1.494 2.549 0 C-N-CA 119.613 -1.28 . . . . 0.0 110.635 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -108.02 -70.7 0.79 Allowed 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.686 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 158.02 -8.48 0.2 Allowed Glycine 0 N--CA 1.488 2.138 0 C-N-CA 119.217 -1.468 . . . . 0.0 110.763 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -150.7 143.77 24.75 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.04 -1.064 . . . . 0.0 111.359 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD13 ' CD1' ' A' ' 111' ' ' PHE . 12.9 mt -90.33 118.37 35.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.738 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.433 ' O ' ' C ' ' A' ' 121' ' ' THR . 8.4 t -95.15 160.47 14.54 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.433 ' C ' ' O ' ' A' ' 120' ' ' SER . 3.4 p -36.79 -50.79 0.86 Allowed 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 120.071 -0.652 . . . . 0.0 111.171 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.584 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 97.3 p -52.63 -67.35 0.26 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.183 -1.007 . . . . 0.0 110.278 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.584 ' N ' ' OG ' ' A' ' 122' ' ' SER . 51.9 mt-10 -59.66 -28.38 67.19 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.19 -1.004 . . . . 0.0 110.225 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -63.81 -60.34 3.41 Favored 'General case' 0 C--N 1.304 -1.372 0 C-N-CA 118.742 -1.183 . . . . 0.0 109.399 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.516 ' O ' ' N ' ' A' ' 129' ' ' ARG . 2.1 ttt180 -42.32 -48.47 5.03 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.144 -0.935 . . . . 0.0 110.351 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -51.41 -48.86 62.51 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.04 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.33 59.03 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.05 -1.06 . . . . 0.0 110.199 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.467 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -65.52 -24.03 67.03 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 118.784 -1.166 . . . . 0.0 111.012 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.516 ' N ' ' O ' ' A' ' 125' ' ' ARG . 1.6 tpt180 -68.66 -44.57 73.82 Favored 'General case' 0 N--CA 1.486 1.325 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.719 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.424 ' C ' HD12 ' A' ' 131' ' ' LEU . 19.1 tttt -63.93 -9.84 17.73 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.654 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.432 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 6.4 mp -103.73 -46.33 4.55 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.153 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.423 ' C ' HD12 ' A' ' 132' ' ' LEU . 3.1 pp -148.97 -173.64 4.42 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.103 -1.039 . . . . 0.0 111.068 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 145.01 83.69 0.06 OUTLIER Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.484 -1.341 . . . . 0.0 110.383 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 134' ' ' HIS . 2.2 p80 -148.8 -23.42 0.31 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 119.35 -0.94 . . . . 0.0 111.075 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.548 ' C ' HG23 ' A' ' 136' ' ' VAL . 4.6 pt20 -88.23 1.37 54.63 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.727 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER 47.51 -157.95 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 C-N-CA 119.559 -0.856 . . . . 0.0 110.875 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 74.98 123.32 0.12 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.423 -1.37 . . . . 0.0 110.18 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -80.18 -28.95 38.63 Favored 'General case' 0 C--N 1.304 -1.413 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.827 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -50.24 -50.14 50.84 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.218 -0.993 . . . . 0.0 110.512 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -44.41 -47.25 9.8 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.439 -0.905 . . . . 0.0 110.791 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.1 mm -59.75 -61.52 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.621 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.17 -35.02 66.74 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.314 -0.955 . . . . 0.0 110.439 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -64.26 -40.23 95.57 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.784 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -67.34 -29.52 46.03 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.387 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.45 HD11 HD23 ' A' ' 124' ' ' LEU . 1.7 mt -85.67 -24.29 6.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.474 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 ttt180 -84.3 -23.36 30.33 Favored 'General case' 0 C--N 1.303 -1.43 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.818 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -79.97 -21.98 43.1 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.414 -0.914 . . . . 0.0 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.4 p -94.21 -9.5 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 119.406 -0.918 . . . . 0.0 110.86 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.26 115.35 8.44 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.008 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 1.1 tp -81.04 -5.94 58.21 Favored 'General case' 0 C--N 1.307 -1.256 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.836 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.525 ' CG ' ' N ' ' A' ' 152' ' ' GLY . 35.7 p-10 -142.74 -135.11 0.1 Allowed 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 119.699 -0.8 . . . . 0.0 110.549 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.525 ' N ' ' CG ' ' A' ' 151' ' ' ASN . . . -96.02 -88.15 1.78 Allowed Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.379 -1.391 . . . . 0.0 109.953 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.59 ' CG ' ' N ' ' A' ' 154' ' ' GLY . 13.4 t0 36.83 -109.8 0.06 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.077 -0.649 . . . . 0.0 111.68 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.59 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 147.6 10.89 0.18 Allowed Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -139.36 162.07 35.91 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.517 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.6 t -88.07 122.76 40.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 111.129 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -105.95 158.84 16.49 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.944 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.66 ' CG ' ' NH1' ' A' ' 105' ' ' ARG . 30.8 t80 -41.52 -35.86 0.79 Allowed 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.36 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -68.53 -62.72 1.27 Allowed 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.507 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' H ' ' HG3' ' A' ' 160' ' ' GLU . 48.6 mt-10 -63.63 -26.61 68.76 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.351 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.676 ' CE2' HD12 ' A' ' 104' ' ' LEU . 8.0 t80 -72.9 -32.62 65.48 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.297 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.505 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.9 t -71.32 -35.79 59.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 C-N-CA 119.387 -0.925 . . . . 0.0 110.27 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.5 mmp_? -73.56 -26.45 60.84 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 119.265 -0.974 . . . . 0.0 110.398 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 7.6 tpt -72.75 -36.37 67.69 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.814 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -35.72 69.76 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 118.927 -1.109 . . . . 0.0 110.632 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.1 t -84.78 137.0 33.45 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.606 -0.837 . . . . 0.0 110.743 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 . . . . . 0 C--N 1.304 -1.374 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.798 179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.824 0.345 . . . . 0.0 110.765 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -95.6 -93.59 0.2 Allowed 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.874 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.59 ' N ' ' SD ' ' A' ' 98' ' ' MET . 0.5 OUTLIER 50.31 -169.31 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.515 -0.874 . . . . 0.0 110.978 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 101' ' ' VAL . 4.4 tp -79.06 157.72 4.75 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.666 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.466 ' N ' HG13 ' A' ' 99' ' ' ILE . . . -71.02 12.62 2.13 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.528 -1.32 . . . . 0.0 111.156 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 99' ' ' ILE . 27.0 t -68.49 -40.36 81.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.538 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.534 ' O ' ' N ' ' A' ' 105' ' ' ARG . 23.6 tptt -50.38 -41.06 51.29 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.508 -1.277 . . . . 0.0 109.825 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 102' ' ' LYS . 24.1 tp10 -44.57 -49.84 9.93 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.811 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.668 HD12 ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -53.05 -39.07 62.97 Favored 'General case' 0 C--N 1.3 -1.572 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.423 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.534 ' N ' ' O ' ' A' ' 102' ' ' LYS . 0.3 OUTLIER -58.81 -41.08 85.94 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.05 -1.06 . . . . 0.0 109.757 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' A' ' 106' ' ' ASP . 0.4 OUTLIER -49.16 -51.96 29.36 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.263 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.417 ' O ' ' C ' ' A' ' 108' ' ' PHE . . . -53.39 -52.09 60.45 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 118.4 -1.32 . . . . 0.0 108.36 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.417 ' C ' ' O ' ' A' ' 107' ' ' ALA . 0.6 OUTLIER -39.73 -37.6 0.55 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.006 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -63.58 -60.24 3.59 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.484 -0.886 . . . . 0.0 109.4 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -53.94 -36.32 62.68 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.593 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.556 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -58.94 -55.9 29.22 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.582 -1.19 . . . . 0.0 109.523 179.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.551 ' OD1' ' ND2' ' A' ' 114' ' ' ASN . 56.8 t0 -109.03 75.73 0.97 Allowed 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.738 -1.119 . . . . 0.0 110.581 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.402 ' O ' ' C ' ' A' ' 114' ' ' ASN . 0.6 OUTLIER -54.61 -54.14 45.44 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.468 -0.893 . . . . 0.0 111.328 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.91 HD22 ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -39.72 -83.67 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.308 179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 149.39 56.98 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 C-N-CA 118.982 -1.58 . . . . 0.0 110.861 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.33 -39.4 6.48 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.878 -0.729 . . . . 0.0 110.516 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 101.04 4.61 54.06 Favored Glycine 0 N--CA 1.494 2.532 0 C-N-CA 119.72 -1.229 . . . . 0.0 110.178 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -151.82 135.26 16.08 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.569 -0.853 . . . . 0.0 110.528 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.556 HD13 ' CD1' ' A' ' 111' ' ' PHE . 14.7 mt -89.25 115.17 28.52 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.831 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 121' ' ' THR . 73.7 m -101.82 161.21 13.83 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.109 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.414 ' C ' ' O ' ' A' ' 120' ' ' SER . 1.5 p -34.92 -53.76 0.57 Allowed 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 120.2 -0.6 . . . . 0.0 111.58 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 t -56.97 -55.05 39.72 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.17 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.409 ' CD ' HD21 ' A' ' 114' ' ' ASN . 7.7 tt0 -65.01 -34.87 79.48 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.102 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.523 ' CD1' ' C ' ' A' ' 124' ' ' LEU . 0.1 OUTLIER -65.05 -60.01 3.5 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 119.204 -0.998 . . . . 0.0 109.366 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' ' CD1' ' A' ' 141' ' ' ILE . 12.4 ttt180 -41.34 -40.34 1.67 Allowed 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.519 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.84 -46.79 83.44 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.798 -1.161 . . . . 0.0 109.669 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.409 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -64.89 -47.93 76.03 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.977 -1.089 . . . . 0.0 109.498 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.573 ' O ' ' N ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -64.78 -44.61 89.46 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.989 -1.084 . . . . 0.0 109.843 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.487 ' HA ' HD23 ' A' ' 132' ' ' LEU . 3.8 ttt-85 -53.98 -28.69 39.34 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 119.128 -1.029 . . . . 0.0 110.97 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.49 ' C ' HD12 ' A' ' 131' ' ' LEU . 21.2 mmtm -75.6 -34.0 60.58 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 118.92 -1.112 . . . . 0.0 111.246 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.2 mp -101.25 -51.6 3.46 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.582 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.573 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.0 OUTLIER 24.0 -131.98 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 O-C-N 124.386 1.053 . . . . 0.0 111.524 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 166.21 -79.28 0.12 Allowed Glycine 0 N--CA 1.487 2.074 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.19 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -88.3 96.73 10.68 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.573 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.486 ' C ' HG12 ' A' ' 136' ' ' VAL . 51.5 mm-40 49.68 -100.73 0.08 Allowed 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.99 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.486 HG12 ' C ' ' A' ' 135' ' ' GLN . 0.2 OUTLIER -173.87 158.09 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.599 -0.841 . . . . 0.0 110.339 -179.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.464 ' N ' ' CG2' ' A' ' 136' ' ' VAL . . . -144.55 143.32 11.89 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.34 -1.41 . . . . 0.0 110.546 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.04 -69.91 0.67 Allowed 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.628 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 3.6 mtm-85 -59.69 -10.21 3.45 Favored 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.571 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -71.7 -70.44 0.33 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.74 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.434 HG23 ' N ' ' A' ' 142' ' ' GLU . 2.0 tt -54.26 -43.5 61.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 C-N-CA 119.23 -0.988 . . . . 0.0 110.851 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.434 ' N ' HG23 ' A' ' 141' ' ' ILE . 2.7 mm-40 -58.58 -49.25 78.15 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.289 -0.964 . . . . 0.0 111.142 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -54.51 -36.93 64.74 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 28.2 mm -69.71 -34.72 62.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.308 0 C-N-CA 119.192 -1.003 . . . . 0.0 110.798 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.1 mt -74.65 -20.2 16.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 C-N-CA 119.349 -0.94 . . . . 0.0 110.466 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 15.7 tpt180 -90.73 -31.2 16.66 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.333 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.16 -13.67 35.16 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.417 -0.913 . . . . 0.0 112.365 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.503 HG11 HG22 ' A' ' 156' ' ' VAL . 4.7 p -89.16 -7.85 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 118.736 -1.186 . . . . 0.0 111.386 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.665 ' OD1' 'CA ' ' A' ' 502' ' ' ' CA' . 29.6 t70 -92.75 108.73 20.21 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 119.286 -0.966 . . . . 0.0 110.823 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 29.5 mt -74.26 -21.36 59.8 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 119.368 -0.933 . . . . 0.0 111.182 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.503 ' ND2' ' N ' ' A' ' 151' ' ' ASN . 0.0 OUTLIER -86.79 -152.37 0.18 Allowed 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.333 -179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -112.28 11.83 26.33 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 119.848 -1.168 . . . . 0.0 111.577 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.26 -82.14 0.09 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 118.72 -1.192 . . . . 0.0 110.748 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 140.13 -30.46 2.34 Favored Glycine 0 N--CA 1.497 2.71 0 C-N-CA 119.331 -1.414 . . . . 0.0 111.058 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -89.08 163.06 15.65 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.045 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.503 HG22 HG11 ' A' ' 148' ' ' VAL . 43.8 t -87.28 136.71 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.281 0 C-N-CA 119.207 -0.997 . . . . 0.0 111.298 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 34.8 t70 -117.94 160.32 21.65 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.372 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.466 ' CE1' ' CG2' ' A' ' 162' ' ' VAL . 20.2 t80 -43.03 -56.15 3.47 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.378 -0.929 . . . . 0.0 110.671 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . 0.503 ' CG ' ' N ' ' A' ' 160' ' ' GLU . 9.5 pt-20 -53.94 -50.24 66.91 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 119.077 -1.049 . . . . 0.0 110.409 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.503 ' N ' ' CG ' ' A' ' 159' ' ' GLU . 7.0 mt-10 -64.32 -46.05 85.22 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.264 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.668 ' CE2' HD12 ' A' ' 104' ' ' LEU . 3.0 t80 -64.22 -37.79 88.72 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.137 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.513 HG22 ' HB3' ' A' ' 104' ' ' LEU . 29.8 t -71.61 -24.12 23.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.906 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -81.53 -21.91 38.25 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.382 -0.927 . . . . 0.0 110.601 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.2 ttt -81.7 -27.6 33.87 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.36 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.425 ' HE3' ' CE1' ' A' ' 161' ' ' PHE . 5.2 ttm -74.69 -53.32 9.49 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 118.726 -1.19 . . . . 0.0 111.239 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 5.3 m -59.88 -179.78 0.11 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 119.614 -0.834 . . . . 0.0 111.262 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 N--CA 1.484 1.242 0 CA-C-O 116.296 -1.811 . . . . 0.0 110.826 -179.988 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . 0.665 'CA ' ' OD1' ' A' ' 149' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.475 ' C ' ' OD1' ' A' ' 97' ' ' ASP . . . . . . . . 0 N--CA 1.484 1.23 0 CA-C-O 120.794 0.331 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.475 ' OD1' ' C ' ' A' ' 96' ' ' ALA . 1.7 m-20 -149.39 -122.58 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 119.434 -0.906 . . . . 0.0 110.893 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 4.8 ttt -87.9 -14.66 38.74 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.826 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 99' ' ' ILE . 17.0 mt -149.45 121.68 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 C-N-CA 119.626 -0.83 . . . . 0.0 110.963 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.523 ' H ' ' HG3' ' A' ' 103' ' ' GLU . . . -120.64 168.21 13.94 Favored Glycine 0 N--CA 1.499 2.876 0 C-N-CA 119.987 -1.101 . . . . 0.0 110.418 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 4.0 m -48.06 -36.07 5.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.581 -0.848 . . . . 0.0 111.234 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 3.7 tttt -61.52 -45.46 94.08 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.362 -1.335 . . . . 0.0 110.191 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.523 ' HG3' ' H ' ' A' ' 100' ' ' GLY . 12.0 mt-10 -49.21 -39.35 29.47 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.259 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.874 HD12 HG22 ' A' ' 162' ' ' VAL . 12.5 mt -59.14 -42.07 89.78 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 118.597 -1.241 . . . . 0.0 108.45 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.415 ' C ' ' O ' ' A' ' 104' ' ' LEU . 1.1 ttt-85 -46.94 -35.54 6.63 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 118.68 -1.208 . . . . 0.0 107.758 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -68.65 -46.31 69.5 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.439 ' N ' ' O ' ' A' ' 104' ' ' LEU . . . -59.45 -53.58 56.47 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.6 -44.27 12.87 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 114.936 -1.029 . . . . 0.0 111.038 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ttt180 -60.35 -54.56 44.23 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 119.279 -0.968 . . . . 0.0 110.773 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -63.15 -22.77 67.09 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 118.986 -1.086 . . . . 0.0 109.796 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.711 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -67.98 -69.48 0.32 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.307 179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.56 71.98 0.21 Allowed 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.963 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 1.7 t -85.05 3.56 38.15 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.464 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -89.97 -20.58 23.13 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.931 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 90.69 70.47 1.21 Allowed Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.387 -1.387 . . . . 0.0 110.415 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 116' ' ' ASP . 4.6 t0 -148.41 -61.41 0.25 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.438 -0.905 . . . . 0.0 111.128 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 144.59 -60.79 0.5 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.445 ' OE1' ' OD2' ' A' ' 157' ' ' ASP . 2.0 mm-40 -98.02 158.18 15.69 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 119.809 -0.756 . . . . 0.0 110.163 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.711 HD13 ' CE1' ' A' ' 111' ' ' PHE . 29.5 mt -88.47 128.11 40.95 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 C-N-CA 118.686 -1.206 . . . . 0.0 111.519 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.511 ' H ' ' HB2' ' A' ' 123' ' ' GLU . 5.6 m -110.88 160.77 16.47 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.132 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.426 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.8 OUTLIER -34.71 -58.84 0.49 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.083 -0.647 . . . . 0.0 111.523 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -51.29 -51.8 50.93 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 118.971 -1.091 . . . . 0.0 109.955 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HB2' ' H ' ' A' ' 120' ' ' SER . 29.7 mt-10 -67.13 -41.36 86.27 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.488 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.51 HD11 ' SD ' ' A' ' 128' ' ' MET . 0.1 OUTLIER -55.09 -56.53 18.76 Favored 'General case' 0 C--N 1.31 -1.152 0 C-N-CA 118.842 -1.143 . . . . 0.0 109.669 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.7 ttt180 -45.55 -52.66 10.15 Favored 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 119.426 -0.91 . . . . 0.0 109.581 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -51.1 -47.28 61.96 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.676 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.577 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -65.21 -56.14 14.52 Favored 'General case' 0 C--N 1.306 -1.286 0 C-N-CA 119.109 -1.036 . . . . 0.0 109.346 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.51 ' SD ' HD11 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -55.96 -23.43 32.17 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.952 -1.099 . . . . 0.0 110.572 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.465 ' NE ' ' OE1' ' A' ' 135' ' ' GLN . 0.0 OUTLIER -67.87 -43.9 78.3 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.108 -1.037 . . . . 0.0 109.786 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -77.4 -36.94 52.93 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.972 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 6.3 mp -84.43 -49.91 8.25 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.243 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.471 ' N ' ' O ' ' A' ' 128' ' ' MET . 0.7 OUTLIER -101.48 -174.69 2.66 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.741 -0.784 . . . . 0.0 110.937 -179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -158.3 93.13 0.13 Allowed Glycine 0 N--CA 1.49 2.273 0 C-N-CA 119.398 -1.382 . . . . 0.0 110.615 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -155.19 -64.22 0.12 Allowed 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.426 -0.91 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.465 ' OE1' ' NE ' ' A' ' 129' ' ' ARG . 51.3 mt-30 45.22 -153.93 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.546 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 136' ' ' VAL . 4.0 t 51.42 30.1 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.184 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.026 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' A' ' 139' ' ' ARG . . . 177.98 62.76 0.07 OUTLIER Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.469 ' ND1' ' N ' ' A' ' 139' ' ' ARG . 3.7 p80 -38.43 -30.11 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 120.173 -0.611 . . . . 0.0 111.551 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.469 ' N ' ' ND1' ' A' ' 138' ' ' HIS . 0.1 OUTLIER -61.17 -19.77 61.95 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.33 -0.948 . . . . 0.0 111.041 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.481 ' O ' ' N ' ' A' ' 143' ' ' GLU . 1.3 m-20 -79.49 -70.7 0.49 Allowed 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.369 -0.933 . . . . 0.0 111.539 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 142' ' ' GLU . 1.9 pp -45.9 -37.23 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 118.869 -1.132 . . . . 0.0 110.29 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.548 ' O ' ' N ' ' A' ' 146' ' ' ARG . 24.5 mt-10 -70.74 -35.36 72.63 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 118.981 -1.088 . . . . 0.0 108.81 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' ASP . 11.0 tt0 -48.09 -37.69 15.81 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 118.553 -1.259 . . . . 0.0 108.361 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.1 mt -79.45 -30.31 13.74 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.489 179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.427 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.7 tt -83.39 -10.52 11.84 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.09 0 C-N-CA 119.471 -0.892 . . . . 0.0 109.68 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 142' ' ' GLU . 20.0 ttp180 -90.45 -51.25 5.51 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.545 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.62 ' C ' ' H ' ' A' ' 149' ' ' ASP . 10.5 t70 -68.34 -52.46 33.06 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.759 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.511 HG21 ' SD ' ' A' ' 164' ' ' MET . 1.5 p -54.8 0.72 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.31 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.717 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 147' ' ' ASP . 50.1 t0 -75.8 177.87 6.59 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 119.269 -0.972 . . . . 0.0 110.719 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.499 ' N ' ' OD1' ' A' ' 149' ' ' ASP . 8.3 tp -158.07 13.29 0.2 Allowed 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.397 -0.921 . . . . 0.0 110.699 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -152.46 -53.57 0.12 Allowed 'General case' 0 C--N 1.304 -1.371 0 C-N-CA 119.146 -1.021 . . . . 0.0 111.047 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.44 -20.97 0.94 Allowed Glycine 0 N--CA 1.49 2.281 0 C-N-CA 119.255 -1.45 . . . . 0.0 110.564 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -10.53 13.21 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 119.362 -0.935 . . . . 0.0 110.689 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 52.47 48.83 54.12 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.388 -1.387 . . . . 0.0 110.146 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 20.8 mtp180 -139.13 160.66 39.28 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 119.875 -0.73 . . . . 0.0 110.68 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 37.1 t -110.6 136.64 46.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 C-N-CA 119.618 -0.833 . . . . 0.0 112.289 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.554 ' OD1' ' N ' ' A' ' 158' ' ' PHE . 8.9 t70 -115.37 160.46 19.81 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.885 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.554 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 20.4 t80 -43.04 -30.06 0.4 Allowed 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 118.767 -1.173 . . . . 0.0 110.584 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -72.85 -63.23 1.21 Allowed 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.32 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -56.78 -28.35 61.14 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.533 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -64.89 -48.99 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 114.924 -1.035 . . . . 0.0 109.193 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.874 HG22 HD12 ' A' ' 104' ' ' LEU . 15.3 t -66.81 -26.76 37.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 CA-C-N 114.702 -1.136 . . . . 0.0 110.13 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -79.73 -27.65 40.57 Favored 'General case' 0 C--N 1.305 -1.355 0 C-N-CA 119.34 -0.944 . . . . 0.0 110.347 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.511 ' SD ' HG21 ' A' ' 148' ' ' VAL . 1.7 tpt -72.52 -31.85 65.67 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 118.889 -1.124 . . . . 0.0 110.155 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -65.92 -45.12 83.04 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.074 -1.05 . . . . 0.0 110.768 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 3.4 m -83.98 -170.31 3.02 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.759 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.417 ' HD3' ' H ' ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 CA-C-O 116.414 -1.755 . . . . 0.0 110.814 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.168 0 CA-C-O 120.954 0.407 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.442 ' N ' ' OD1' ' A' ' 97' ' ' ASP . 31.3 p-10 -72.09 -1.98 16.81 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.36 -0.936 . . . . 0.0 110.698 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -172.44 -84.85 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.632 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 99' ' ' ILE . 92.1 mt -144.82 -6.21 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 119.54 -0.864 . . . . 0.0 110.704 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 80.01 98.6 0.31 Allowed Glycine 0 N--CA 1.488 2.159 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.449 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.621 ' CG1' ' N ' ' A' ' 102' ' ' LYS . 3.2 p -80.11 -46.01 22.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.873 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.621 ' N ' ' CG1' ' A' ' 101' ' ' VAL . 1.0 OUTLIER -49.45 -44.7 45.83 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.226 -1.39 . . . . 0.0 109.863 -179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -47.32 -42.86 22.04 Favored 'General case' 0 C--N 1.31 -1.144 0 C-N-CA 118.769 -1.172 . . . . 0.0 109.166 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.63 HD12 HG22 ' A' ' 162' ' ' VAL . 19.0 mt -61.96 -33.24 73.93 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 118.504 -1.279 . . . . 0.0 108.725 179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 102' ' ' LYS . 18.3 ttt180 -51.03 -36.08 37.71 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -63.72 -46.92 83.21 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.165 179.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -59.03 -54.51 46.31 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 119.059 -1.056 . . . . 0.0 108.307 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.539 ' CD1' ' CD2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -45.72 -38.46 6.96 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.408 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.0 mtp85 -69.44 -54.42 14.41 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 119.02 -1.072 . . . . 0.0 109.717 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -57.57 -23.51 51.05 Favored 'General case' 0 C--N 1.309 -1.158 0 C-N-CA 118.977 -1.089 . . . . 0.0 108.858 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.533 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -66.73 -64.05 0.94 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-N 114.749 -1.114 . . . . 0.0 109.854 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -80.73 130.89 35.33 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.821 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.67 19.53 5.35 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.763 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.468 ' ND2' ' HB3' ' A' ' 116' ' ' ASP . 33.2 p-10 -144.54 0.84 1.02 Allowed 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 119.52 -0.872 . . . . 0.0 110.911 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 52.66 56.61 17.21 Favored Glycine 0 N--CA 1.49 2.236 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.708 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.622 ' CG ' ' H ' ' A' ' 117' ' ' GLY . 15.1 p-10 -86.95 -60.25 2.03 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.905 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.622 ' H ' ' CG ' ' A' ' 116' ' ' ASP . . . 151.79 -14.01 0.78 Allowed Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.242 -1.456 . . . . 0.0 110.33 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.509 ' CD ' ' C ' ' A' ' 117' ' ' GLY . 29.7 mp0 -147.92 142.51 26.54 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 119.848 -0.741 . . . . 0.0 110.416 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.533 HD13 ' CD1' ' A' ' 111' ' ' PHE . 32.2 mt -88.92 109.69 20.48 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 C-N-CA 118.98 -1.088 . . . . 0.0 110.706 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.44 ' O ' ' C ' ' A' ' 121' ' ' THR . 5.4 t -98.51 161.18 13.81 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.652 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.44 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.6 OUTLIER -36.34 -47.71 0.61 Allowed 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.928 -0.709 . . . . 0.0 111.141 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.7 t -58.37 -57.43 12.96 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.767 -1.173 . . . . 0.0 109.257 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -62.23 -36.46 82.03 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.577 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.692 ' HB2' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -58.7 -53.25 60.44 Favored 'General case' 0 C--N 1.309 -1.182 0 C-N-CA 119.016 -1.073 . . . . 0.0 109.242 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -44.89 -50.3 10.49 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.072 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -54.19 -38.36 65.53 Favored 'General case' 0 C--N 1.305 -1.326 0 C-N-CA 118.876 -1.13 . . . . 0.0 109.818 179.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.403 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -70.57 -59.66 2.71 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.987 -1.085 . . . . 0.0 109.136 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.789 ' SD ' HD11 ' A' ' 132' ' ' LEU . 1.9 mmt -53.69 -32.88 53.5 Favored 'General case' 0 C--O 1.204 -1.333 0 C-N-CA 118.531 -1.267 . . . . 0.0 109.625 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.515 ' O ' ' N ' ' A' ' 131' ' ' LEU . 1.2 tpt180 -56.0 -54.03 49.75 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.8 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 131' ' ' LEU . 14.6 mmtt -49.47 -9.42 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.465 -0.894 . . . . 0.0 111.247 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 130' ' ' LYS . 8.3 mp -124.06 -41.4 2.21 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 119.882 -0.727 . . . . 0.0 111.319 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.789 HD11 ' SD ' ' A' ' 128' ' ' MET . 5.9 mt -109.96 -137.79 0.37 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.129 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' A' ' 135' ' ' GLN . . . 176.24 161.6 25.61 Favored Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.639 -1.267 . . . . 0.0 110.144 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -52.35 88.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.355 -0.938 . . . . 0.0 110.857 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 133' ' ' GLY . 33.1 mm-40 -95.93 -49.44 5.3 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.16 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.481 HG23 ' N ' ' A' ' 137' ' ' GLY . 29.2 m -148.19 -130.13 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 C-N-CA 119.307 -0.957 . . . . 0.0 111.131 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.481 ' N ' HG23 ' A' ' 136' ' ' VAL . . . -79.65 171.26 54.61 Favored Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.371 -1.395 . . . . 0.0 110.797 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 139' ' ' ARG . 6.7 p-80 -90.28 -8.74 50.18 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.854 -0.738 . . . . 0.0 110.576 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 138' ' ' HIS . 42.2 ttt-85 -36.65 -39.08 0.19 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.549 -0.751 . . . . 0.0 111.315 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -66.65 -48.54 69.07 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.373 -0.931 . . . . 0.0 110.582 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 138' ' ' HIS . 8.6 mt -48.44 -61.24 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 C-N-CA 119.571 -0.852 . . . . 0.0 111.035 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -53.6 -37.93 63.49 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.182 -1.007 . . . . 0.0 110.819 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.405 ' OE2' ' OD1' ' A' ' 147' ' ' ASP . 8.1 tm-20 -57.33 -34.93 69.27 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.315 -0.954 . . . . 0.0 110.765 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 48.1 mm -76.82 -29.6 17.89 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 C-N-CA 119.388 -0.925 . . . . 0.0 110.773 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.692 HD11 ' HB2' ' A' ' 124' ' ' LEU . 56.8 mt -89.52 -17.88 7.98 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.313 0 C-N-CA 119.489 -0.885 . . . . 0.0 111.224 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 27.0 ttp180 -88.88 -32.06 17.94 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.232 -0.987 . . . . 0.0 110.723 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.405 ' OD1' ' OE2' ' A' ' 143' ' ' GLU . 3.1 m-20 -69.89 -19.29 63.42 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.433 -0.907 . . . . 0.0 111.015 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.523 HG11 HG22 ' A' ' 156' ' ' VAL . 1.0 OUTLIER -102.22 -0.43 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.77 -0.772 . . . . 0.0 110.986 -179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.545 ' OD1' ' ND2' ' A' ' 151' ' ' ASN . 0.2 OUTLIER -82.0 100.5 9.74 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 119.141 -1.023 . . . . 0.0 110.995 -179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 55.1 tp -66.4 -31.81 72.81 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.692 -0.803 . . . . 0.0 110.559 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.786 HD22 ' H ' ' A' ' 152' ' ' GLY . 0.1 OUTLIER -86.12 -77.97 0.29 Allowed 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.676 -0.809 . . . . 0.0 110.92 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.786 ' H ' HD22 ' A' ' 151' ' ' ASN . . . 151.29 20.62 0.06 OUTLIER Glycine 0 N--CA 1.49 2.256 0 C-N-CA 119.284 -1.436 . . . . 0.0 110.466 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.09 -58.68 3.14 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.164 -1.015 . . . . 0.0 110.663 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 132.35 25.46 0.72 Allowed Glycine 0 N--CA 1.496 2.686 0 C-N-CA 119.816 -1.183 . . . . 0.0 110.331 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 11.5 mtp180 -145.73 156.93 43.93 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 119.342 -0.943 . . . . 0.0 111.31 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.523 HG22 HG11 ' A' ' 148' ' ' VAL . 2.9 t -98.0 142.6 14.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 119.334 -0.946 . . . . 0.0 111.618 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.507 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 0.7 OUTLIER -112.29 157.78 20.53 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.782 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.63 ' O ' HG23 ' A' ' 162' ' ' VAL . 33.6 t80 -44.01 -51.77 7.54 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.018 -1.073 . . . . 0.0 110.655 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -59.85 -51.72 68.51 Favored 'General case' 0 C--N 1.306 -1.326 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.725 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.507 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 63.0 mt-10 -62.22 -35.84 80.13 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.73 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.539 ' CD2' ' CD1' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -70.96 -38.69 72.81 Favored 'General case' 0 C--N 1.306 -1.296 0 C-N-CA 119.11 -1.036 . . . . 0.0 110.039 179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.63 HG22 HD12 ' A' ' 104' ' ' LEU . 40.7 t -55.2 -50.37 64.78 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 C-N-CA 119.271 -0.972 . . . . 0.0 110.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 22.5 ttm-85 -67.37 -31.25 71.37 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.086 -1.046 . . . . 0.0 110.344 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 5.6 tpt -66.96 -18.63 65.47 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 118.631 -1.228 . . . . 0.0 109.724 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . 0.548 ' O ' ' N ' ' A' ' 167' ' ' ARG . 13.0 ttm -88.44 -79.97 0.29 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 118.889 -1.125 . . . . 0.0 110.894 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.508 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 1.4 t 51.09 -86.06 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.837 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.548 ' N ' ' O ' ' A' ' 165' ' ' MET . 2.1 mmp_? . . . . . 0 C--N 1.307 -1.247 0 CA-C-O 116.386 -1.768 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.751 0.31 . . . . 0.0 110.792 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -105.05 88.29 2.84 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.961 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 3.6 ptt? -101.54 -178.75 3.82 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.764 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.454 HG23 ' N ' ' A' ' 100' ' ' GLY . 0.9 OUTLIER 63.66 161.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.759 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.454 ' N ' HG23 ' A' ' 99' ' ' ILE . . . 173.94 117.87 0.48 Allowed Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.511 -1.328 . . . . 0.0 110.292 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.425 ' H ' HG22 ' A' ' 101' ' ' VAL . 3.6 m -68.33 -16.95 21.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 C-N-CA 119.285 -0.966 . . . . 0.0 110.979 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.511 ' O ' ' N ' ' A' ' 105' ' ' ARG . 17.1 mtpp -51.69 -45.92 63.66 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 118.581 -1.248 . . . . 0.0 109.939 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' O ' ' N ' ' A' ' 106' ' ' ASP . 18.7 tt0 -47.94 -46.16 31.86 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 118.49 -1.284 . . . . 0.0 108.408 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.758 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.09 -37.64 22.03 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.511 ' N ' ' O ' ' A' ' 102' ' ' LYS . 4.8 ttt85 -59.2 -39.98 84.35 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.749 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 103' ' ' GLU . 11.4 t70 -48.39 -47.81 37.28 Favored 'General case' 0 C--O 1.21 -0.986 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.91 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.02 -56.62 17.13 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.54 -1.264 . . . . 0.0 108.233 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.625 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -40.63 -35.37 0.46 Allowed 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.865 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.551 ' C ' ' H ' ' A' ' 111' ' ' PHE . 0.3 OUTLIER -68.19 -64.61 0.83 Allowed 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 118.835 -1.146 . . . . 0.0 109.455 179.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.59 ' OE2' ' NZ ' ' A' ' 130' ' ' LYS . 4.4 tm-20 -52.18 -9.9 0.11 Allowed 'General case' 0 C--N 1.31 -1.139 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.102 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.551 ' H ' ' C ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -85.26 -64.14 1.21 Allowed 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.702 -1.135 . . . . 0.0 110.219 179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -88.56 123.32 32.94 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.113 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -98.37 5.3 48.31 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.399 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -105.45 -129.1 0.26 Allowed 'General case' 0 N--CA 1.487 1.397 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.714 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -146.4 -4.22 0.48 Allowed Glycine 0 N--CA 1.492 2.43 0 C-N-CA 119.198 -1.477 . . . . 0.0 111.042 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.616 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 14.8 p30 -56.94 -52.08 66.63 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.392 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.616 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 102.86 25.67 7.47 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -149.87 138.35 20.68 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.612 -0.835 . . . . 0.0 110.335 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.49 HD13 ' CE1' ' A' ' 111' ' ' PHE . 20.9 mt -89.24 118.81 35.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.651 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.418 ' O ' ' N ' ' A' ' 124' ' ' LEU . 50.7 p -90.61 160.51 15.87 Favored 'General case' 0 C--N 1.309 -1.163 0 C-N-CA 119.521 -0.872 . . . . 0.0 111.811 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 124' ' ' LEU . 1.4 p -40.99 -70.4 0.11 Allowed 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.053 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.523 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 25.2 p -47.68 -50.58 24.49 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.868 -1.133 . . . . 0.0 109.874 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.523 ' N ' ' OG ' ' A' ' 122' ' ' SER . 27.1 mt-10 -57.24 -23.51 48.58 Favored 'General case' 0 C--N 1.306 -1.308 0 C-N-CA 119.171 -1.012 . . . . 0.0 109.645 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.456 HD22 HG21 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -69.53 -53.09 20.71 Favored 'General case' 0 C--N 1.307 -1.28 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.301 179.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 37.7 mtp180 -46.64 -49.02 19.77 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.419 -0.913 . . . . 0.0 109.902 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 -57.92 -40.67 80.97 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 118.788 -1.165 . . . . 0.0 109.592 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 111' ' ' PHE . . . -68.82 -56.35 8.25 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.116 -1.034 . . . . 0.0 109.461 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.563 ' HG3' HG22 ' A' ' 141' ' ' ILE . 0.0 OUTLIER -49.04 -37.69 21.64 Favored 'General case' 0 C--N 1.311 -1.097 0 C-N-CA 119.101 -1.04 . . . . 0.0 110.338 179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 6.2 ttp85 -67.75 -34.08 76.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 119.246 -0.982 . . . . 0.0 110.818 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.59 ' NZ ' ' OE2' ' A' ' 110' ' ' GLU . 0.0 OUTLIER -63.91 -32.01 73.39 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.905 179.978 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 7.5 mp -92.91 -46.79 7.33 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.732 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.604 ' N ' HD12 ' A' ' 132' ' ' LEU . 8.7 mp -82.5 169.13 16.7 Favored 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.226 -0.989 . . . . 0.0 110.543 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -89.73 -114.22 1.49 Allowed Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.35 -1.405 . . . . 0.0 110.182 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.611 ' H ' ' CD2' ' A' ' 134' ' ' HIS . 8.2 m-70 -68.78 157.94 35.36 Favored 'General case' 0 C--N 1.304 -1.407 0 C-N-CA 119.383 -0.927 . . . . 0.0 110.781 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 6.3 mp0 -68.31 167.42 14.51 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 119.445 -0.902 . . . . 0.0 110.997 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 m -148.19 -16.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.63 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 147.71 129.39 1.9 Allowed Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.517 -1.325 . . . . 0.0 110.403 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -10.27 51.36 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.442 -0.903 . . . . 0.0 111.045 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 9.7 mtt85 -70.42 -19.36 62.99 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.64 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.98 -53.32 5.37 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 119.472 -0.891 . . . . 0.0 111.532 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.563 HG22 ' HG3' ' A' ' 128' ' ' MET . 1.9 pp -56.86 -39.48 65.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 C-N-CA 118.801 -1.159 . . . . 0.0 110.737 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.488 ' O ' ' N ' ' A' ' 145' ' ' ILE . 61.5 mm-40 -69.47 -46.07 67.52 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.997 -1.081 . . . . 0.0 109.178 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -46.2 -35.69 5.35 Favored 'General case' 0 C--N 1.313 -0.987 0 C-N-CA 119.006 -1.078 . . . . 0.0 109.204 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 7.9 mm -80.81 -29.97 11.79 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 119.225 -0.99 . . . . 0.0 109.427 179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 142' ' ' GLU . 1.5 tt -77.53 -14.99 14.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.143 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.666 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -63.63 1.24 Allowed 'General case' 0 N--CA 1.485 1.284 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.017 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -39.99 -35.47 0.37 Allowed 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.894 -0.723 . . . . 0.0 111.351 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.897 HG13 ' H ' ' A' ' 149' ' ' ASP . 12.9 p -66.56 -116.92 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.469 -0.892 . . . . 0.0 110.253 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.897 ' H ' HG13 ' A' ' 148' ' ' VAL . 33.0 t70 49.11 -168.16 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.657 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.638 ' H ' ' CG ' ' A' ' 149' ' ' ASP . 14.0 tp -166.7 -42.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.623 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -91.91 -87.83 0.21 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.673 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -161.1 -12.81 0.03 OUTLIER Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.668 ' CG ' ' H ' ' A' ' 155' ' ' ARG . 0.3 OUTLIER -47.08 -73.2 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.748 -0.726 . . . . 0.0 110.694 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 153' ' ' ASP . . . 118.55 -17.58 11.14 Favored Glycine 0 N--CA 1.497 2.72 0 C-N-CA 119.915 -1.136 . . . . 0.0 110.814 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.668 ' H ' ' CG ' ' A' ' 153' ' ' ASP . 15.3 mtp180 -88.69 159.82 17.64 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 118.934 -1.106 . . . . 0.0 110.36 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -95.45 148.17 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.344 -0.942 . . . . 0.0 112.537 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' A' ' 161' ' ' PHE . 0.7 OUTLIER -133.25 159.93 38.78 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.625 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 26.6 t80 -42.2 -41.03 2.57 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.185 -1.006 . . . . 0.0 111.152 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -69.26 -61.6 1.72 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.049 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -59.82 -22.46 62.26 Favored 'General case' 0 C--N 1.308 -1.225 0 C-N-CA 119.189 -1.004 . . . . 0.0 109.841 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.758 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 17.0 t80 -77.38 -35.47 54.43 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.119 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.729 HG22 ' HG ' ' A' ' 104' ' ' LEU . 4.4 t -75.93 -34.95 28.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 119.391 -0.924 . . . . 0.0 110.685 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.78 -26.26 57.18 Favored 'General case' 0 C--N 1.308 -1.213 0 C-N-CA 119.097 -1.041 . . . . 0.0 110.46 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.46 ' SD ' ' HB ' ' A' ' 148' ' ' VAL . 10.4 ttp -76.05 -36.58 58.98 Favored 'General case' 0 C--N 1.309 -1.153 0 C-N-CA 118.648 -1.221 . . . . 0.0 110.42 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 5.0 mmt -56.4 -24.82 47.28 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 119.239 -0.984 . . . . 0.0 110.504 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 4.8 p -45.47 144.92 1.36 Allowed 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.579 -0.848 . . . . 0.0 110.958 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.499 ' HG2' HH11 ' A' ' 167' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.333 0 CA-C-O 116.443 -1.741 . . . . 0.0 110.801 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.25 0 CA-C-O 120.79 0.329 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -84.04 -62.83 1.47 Allowed 'General case' 0 C--N 1.305 -1.337 0 C-N-CA 119.346 -0.942 . . . . 0.0 110.829 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 7.4 mtt 48.15 74.67 0.16 Allowed 'General case' 0 C--N 1.305 -1.356 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.724 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 2.8 mm 48.62 54.97 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.659 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -145.58 71.69 0.35 Allowed Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.075 -1.536 . . . . 0.0 111.464 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.446 ' H ' HG23 ' A' ' 101' ' ' VAL . 0.3 OUTLIER -83.78 -15.69 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.094 179.869 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 105' ' ' ARG . 13.7 ptpt -51.44 -37.61 49.54 Favored 'General case' 0 C--N 1.303 -1.446 0 C-N-CA 118.82 -1.152 . . . . 0.0 109.955 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 102' ' ' LYS . 60.7 mm-40 -45.58 -47.33 14.57 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.692 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -55.14 -43.89 74.6 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 179.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 102' ' ' LYS . 34.8 ttm-85 -57.28 -38.53 74.08 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 119.19 -1.004 . . . . 0.0 109.046 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -48.12 -49.81 30.72 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 118.923 -1.111 . . . . 0.0 108.644 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.61 -51.61 67.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.552 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.476 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 3.1 t80 -46.45 -36.57 6.73 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.044 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 19.1 mmm180 -67.76 -57.1 6.91 Favored 'General case' 0 C--N 1.308 -1.228 0 C-N-CA 118.787 -1.165 . . . . 0.0 109.78 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -54.92 -32.27 60.99 Favored 'General case' 0 C--N 1.307 -1.266 0 C-N-CA 118.994 -1.083 . . . . 0.0 109.3 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.714 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -54.24 -57.99 9.08 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.921 179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -83.32 133.07 34.98 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.521 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -93.75 -3.38 52.28 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 119.605 -0.838 . . . . 0.0 110.908 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.854 ' ND2' ' H ' ' A' ' 114' ' ' ASN . 0.0 OUTLIER -111.48 -107.27 0.36 Allowed 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.763 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.408 ' H ' ' CG ' ' A' ' 114' ' ' ASN . . . -179.28 45.1 0.08 OUTLIER Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.532 -1.318 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -87.66 -78.72 0.31 Allowed 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 119.381 -0.928 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 157.19 -7.48 0.21 Allowed Glycine 0 N--CA 1.492 2.37 0 C-N-CA 119.298 -1.429 . . . . 0.0 110.536 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -144.66 143.77 30.91 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.7 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.714 HD13 ' CD1' ' A' ' 111' ' ' PHE . 6.5 mt -89.6 137.28 21.68 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.2 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 34.2 p -115.85 160.77 19.73 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.209 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.524 ' OG1' ' N ' ' A' ' 122' ' ' SER . 77.2 p -38.87 -69.48 0.12 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 119.689 -0.804 . . . . 0.0 110.99 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.534 ' OG ' ' N ' ' A' ' 123' ' ' GLU . 88.7 p -43.25 -65.28 0.51 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.821 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.534 ' N ' ' OG ' ' A' ' 122' ' ' SER . 34.6 mt-10 -52.38 -31.37 33.54 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.548 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.837 HD21 ' SD ' ' A' ' 128' ' ' MET . 4.4 tt -70.55 -46.26 63.9 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 117.969 -1.492 . . . . 0.0 109.826 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' LEU . 9.6 mtm-85 -43.85 -42.28 5.6 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.049 -1.061 . . . . 0.0 108.932 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 32.4 tp10 -65.53 -39.04 91.31 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 118.852 -1.139 . . . . 0.0 109.203 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -67.89 -51.59 46.31 Favored 'General case' 0 C--O 1.21 -1.005 0 C-N-CA 119.034 -1.066 . . . . 0.0 109.868 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . 0.837 ' SD ' HD21 ' A' ' 124' ' ' LEU . 0.0 OUTLIER -59.13 -14.64 10.86 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 118.903 -1.119 . . . . 0.0 110.197 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 35.2 ttm180 -90.65 -23.07 20.89 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.096 -1.041 . . . . 0.0 110.112 179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 5.1 tptm -90.69 -39.14 12.62 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.841 -0.744 . . . . 0.0 112.188 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 4.7 mp -71.07 -54.97 9.27 Favored 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.205 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.415 ' H ' HD12 ' A' ' 132' ' ' LEU . 0.2 OUTLIER -139.34 144.04 38.08 Favored 'General case' 0 N--CA 1.496 1.847 0 C-N-CA 119.298 -0.961 . . . . 0.0 111.143 179.956 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.74 87.92 0.04 OUTLIER Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.573 -1.299 . . . . 0.0 110.532 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 30.3 t-80 -96.28 128.38 43.14 Favored 'General case' 0 C--N 1.306 -1.289 0 C-N-CA 119.577 -0.849 . . . . 0.0 110.644 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -62.12 176.57 0.57 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.855 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG23 ' H ' ' A' ' 136' ' ' VAL . 1.9 t -70.61 164.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.419 -0.913 . . . . 0.0 110.732 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 149.02 79.92 0.03 OUTLIER Glycine 0 N--CA 1.489 2.233 0 C-N-CA 119.434 -1.365 . . . . 0.0 110.346 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.55 ' N ' ' CD2' ' A' ' 138' ' ' HIS . 10.0 m170 -56.16 -67.61 0.28 Allowed 'General case' 0 C--N 1.305 -1.366 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.768 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 1.6 mmt180 -44.47 -40.75 5.79 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 119.446 -0.902 . . . . 0.0 110.857 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.11 -69.91 0.14 Allowed 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.965 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.2 mt -47.03 -56.39 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.561 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -46.4 -44.55 17.25 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.023 -1.071 . . . . 0.0 110.172 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -48.31 -47.96 36.37 Favored 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 119.045 -1.062 . . . . 0.0 109.836 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 144' ' ' ILE . 6.3 mm -56.99 -56.64 13.57 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.869 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.453 ' O ' HG12 ' A' ' 148' ' ' VAL . 1.5 mm -45.38 -26.62 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 C-N-CA 119.482 -0.887 . . . . 0.0 110.504 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.3 tmm_? -90.64 -54.77 3.84 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.719 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.591 ' OD1' ' N ' ' A' ' 148' ' ' VAL . 35.3 p30 -50.65 -15.82 0.32 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.862 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.665 HG11 ' CG2' ' A' ' 156' ' ' VAL . 4.0 p -90.49 -27.05 5.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.981 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.49 ' C ' ' H ' ' A' ' 151' ' ' ASN . 72.2 m-20 -63.27 93.0 0.06 Allowed 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 3.1 pp -67.02 7.56 0.38 Allowed 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.961 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.49 ' H ' ' C ' ' A' ' 149' ' ' ASP . 0.3 OUTLIER -136.69 -94.54 0.23 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 119.734 -0.787 . . . . 0.0 110.859 179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -171.51 11.75 0.04 OUTLIER Glycine 0 N--CA 1.492 2.412 0 C-N-CA 119.129 -1.51 . . . . 0.0 110.756 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 153' ' ' ASP . 0.0 OUTLIER -53.91 -60.36 3.43 Favored 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.826 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 117.62 -0.87 18.14 Favored Glycine 0 N--CA 1.5 2.964 0 C-N-CA 120.007 -1.092 . . . . 0.0 110.402 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 2.2 mpp_? -149.92 162.19 40.83 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.746 -0.781 . . . . 0.0 110.421 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.665 ' CG2' HG11 ' A' ' 148' ' ' VAL . 41.4 t -88.9 148.1 4.76 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.298 0 C-N-CA 119.439 -0.904 . . . . 0.0 111.846 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.441 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 4.6 m-20 -128.4 160.55 31.89 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.132 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.476 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 18.2 t80 -45.79 -32.3 2.48 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.433 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -74.4 -56.29 5.02 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.747 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.441 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 19.2 mt-10 -64.56 -30.59 71.62 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.208 -0.997 . . . . 0.0 109.686 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.692 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.2 t80 -66.97 -39.14 87.12 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.097 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.611 HG22 ' HG ' ' A' ' 104' ' ' LEU . 3.8 t -71.49 -23.87 23.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 119.499 -0.881 . . . . 0.0 110.32 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' A' ' 163' ' ' ARG . 0.0 OUTLIER -85.15 -19.09 32.31 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.648 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 4.7 tmm? -90.15 -21.08 22.4 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.294 -1.362 . . . . 0.0 110.347 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 35.6 tpp -86.09 -54.92 4.19 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.942 -1.103 . . . . 0.0 110.758 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 17.5 m -55.66 168.84 0.37 Allowed 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.178 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 27.8 ttm180 . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 116.32 -1.8 . . . . 0.0 110.997 -179.967 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 120.875 0.369 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -69.1 -39.06 79.21 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 119.354 -0.938 . . . . 0.0 110.893 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 47.0 mmm -72.84 113.11 9.51 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.766 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.0 tp -92.76 -8.46 10.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 C-N-CA 119.471 -0.891 . . . . 0.0 110.814 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -76.86 58.89 3.48 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 119.529 -1.32 . . . . 0.0 110.626 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.409 ' O ' ' C ' ' A' ' 102' ' ' LYS . 21.8 m -55.96 -30.39 28.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 C-N-CA 119.451 -0.9 . . . . 0.0 110.663 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.429 ' O ' ' CB ' ' A' ' 105' ' ' ARG . 20.7 mttm -44.02 -44.97 7.68 Favored 'General case' 0 C--N 1.306 -1.285 0 C-N-CA 118.958 -1.097 . . . . 0.0 110.361 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -50.39 -48.01 56.11 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 118.489 -1.284 . . . . 0.0 109.107 179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.805 HD12 HG22 ' A' ' 162' ' ' VAL . 40.1 mt -57.32 -31.71 65.96 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 118.818 -1.153 . . . . 0.0 108.912 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.429 ' CB ' ' O ' ' A' ' 102' ' ' LYS . 3.7 ttp180 -51.87 -40.69 61.04 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 179.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -60.37 -49.29 78.18 Favored 'General case' 0 C--N 1.313 -0.98 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.23 -57.69 11.76 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -41.6 -39.6 1.66 Allowed 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.34 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.446 ' C ' ' N ' ' A' ' 111' ' ' PHE . 1.4 mtp180 -66.04 -62.35 1.54 Allowed 'General case' 0 C--N 1.308 -1.21 0 C-N-CA 119.163 -1.015 . . . . 0.0 110.022 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -53.26 -17.92 2.06 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 118.886 -1.126 . . . . 0.0 109.188 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.697 ' CE1' HD13 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -74.88 -69.6 0.46 Allowed 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.916 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 115' ' ' GLY . 10.5 m-20 -78.18 107.96 11.14 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.97 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.51 10.31 2.69 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.14 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.764 ' ND2' ' N ' ' A' ' 116' ' ' ASP . 0.3 OUTLIER -125.95 -27.75 3.27 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.74 ' N ' ' ND2' ' A' ' 114' ' ' ASN . . . 72.14 55.59 6.95 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.361 -1.4 . . . . 0.0 110.356 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.764 ' N ' ' ND2' ' A' ' 114' ' ' ASN . 72.7 m-20 -88.6 -38.85 14.54 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.522 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 141.79 -29.96 2.2 Favored Glycine 0 N--CA 1.485 1.925 0 C-N-CA 119.637 -1.268 . . . . 0.0 110.309 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -150.29 153.56 36.36 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.372 -0.931 . . . . 0.0 111.128 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.697 HD13 ' CE1' ' A' ' 111' ' ' PHE . 6.0 mt -89.52 111.51 23.1 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.157 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.195 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 124' ' ' LEU . 7.9 t -89.06 160.56 17.0 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.947 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 ' C ' ' O ' ' A' ' 120' ' ' SER . 0.2 OUTLIER -37.74 -67.1 0.21 Allowed 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.207 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.4 -49.8 33.47 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 118.829 -1.148 . . . . 0.0 109.596 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -63.65 -24.34 67.75 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.419 -0.912 . . . . 0.0 110.259 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 120' ' ' SER . 0.1 OUTLIER -65.24 -62.36 1.58 Allowed 'General case' 0 C--N 1.311 -1.098 0 C-N-CA 118.47 -1.292 . . . . 0.0 109.488 179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 129' ' ' ARG . 14.2 ttt180 -43.82 -45.77 7.52 Favored 'General case' 0 C--O 1.209 -1.051 0 C-N-CA 119.481 -0.888 . . . . 0.0 109.662 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -54.12 -39.85 66.81 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 118.666 -1.214 . . . . 0.0 109.325 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.482 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -71.15 -58.64 3.36 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.561 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 42.0 mtt -61.83 -18.98 62.02 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.171 -1.011 . . . . 0.0 110.495 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.538 ' N ' ' O ' ' A' ' 125' ' ' ARG . 55.8 ttt180 -78.53 -41.57 31.87 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.398 -0.921 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.477 ' C ' HD12 ' A' ' 131' ' ' LEU . 14.8 tttm -63.04 -21.53 66.22 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.436 -0.906 . . . . 0.0 111.021 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.477 HD12 ' C ' ' A' ' 130' ' ' LYS . 7.9 mp -102.76 -44.67 5.23 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.177 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.809 HD12 ' N ' ' A' ' 133' ' ' GLY . 3.6 pp -146.65 -144.93 0.16 Allowed 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.828 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.809 ' N ' HD12 ' A' ' 132' ' ' LEU . . . 106.94 165.17 22.3 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.483 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 4.2 t-80 -150.24 -129.06 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 119.453 -0.899 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . 0.531 ' CG ' ' H ' ' A' ' 136' ' ' VAL . 9.4 tt0 -55.63 -179.47 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.933 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.531 ' H ' ' CG ' ' A' ' 135' ' ' GLN . 2.0 t -85.65 166.19 2.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.76 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 151.31 70.59 0.01 OUTLIER Glycine 0 N--CA 1.49 2.244 0 C-N-CA 119.262 -1.447 . . . . 0.0 110.61 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -46.4 -30.26 2.06 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.258 -0.977 . . . . 0.0 110.671 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -63.65 -22.98 67.19 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 119.347 -0.941 . . . . 0.0 110.833 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -68.79 -70.59 0.26 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.414 -0.914 . . . . 0.0 111.254 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.0 mm -47.83 -50.0 10.12 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 C-N-CA 119.541 -0.864 . . . . 0.0 111.291 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.426 ' N ' ' OE1' ' A' ' 142' ' ' GLU . 0.2 OUTLIER -50.69 -51.35 50.36 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.734 179.969 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -51.62 -47.93 63.47 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.631 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.411 ' N ' HD12 ' A' ' 144' ' ' ILE . 1.7 mp -58.37 -45.03 89.71 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.71 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.2 mt -66.02 -25.03 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 C-N-CA 119.233 -0.987 . . . . 0.0 110.779 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 16.3 tpp85 -72.85 -33.59 66.22 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.417 -0.913 . . . . 0.0 111.119 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -77.7 -47.93 17.94 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.393 -0.923 . . . . 0.0 111.692 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 149' ' ' ASP . 7.3 p -60.15 -49.09 85.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.138 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.698 ' N ' HG13 ' A' ' 148' ' ' VAL . 9.2 m-20 -53.05 132.89 38.61 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.257 -0.977 . . . . 0.0 110.664 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 7.8 mp -80.37 -55.77 4.66 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.067 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -66.21 -85.1 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.411 -0.916 . . . . 0.0 110.929 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 162.9 27.76 0.02 OUTLIER Glycine 0 N--CA 1.49 2.243 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.176 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 154' ' ' GLY . 3.0 p30 -75.91 -34.25 59.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.783 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.548 ' N ' ' OD1' ' A' ' 153' ' ' ASP . . . 91.56 24.63 25.49 Favored Glycine 0 N--CA 1.488 2.163 0 C-N-CA 119.306 -1.426 . . . . 0.0 110.299 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -151.06 160.5 43.86 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.644 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 58.9 t -115.57 141.93 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 C-N-CA 119.814 -0.755 . . . . 0.0 111.62 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.55 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 13.8 t70 -128.41 160.49 32.09 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.442 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.697 ' O ' HG23 ' A' ' 162' ' ' VAL . 8.7 t80 -36.74 -36.05 0.1 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 119.68 -0.808 . . . . 0.0 111.204 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -71.5 -61.45 1.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.633 -1.227 . . . . 0.0 108.97 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.55 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 21.5 mt-10 -58.3 -32.79 68.79 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.555 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -53.85 -42.42 68.52 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.998 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.805 HG22 HD12 ' A' ' 104' ' ' LEU . 90.3 t -68.34 -30.7 48.56 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.01 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 2.7 tpp85 -77.02 -25.29 52.44 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 119.401 -0.919 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 21.1 ttt -75.96 -33.16 59.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 118.893 -1.123 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 10.9 mmt -61.79 -42.75 99.4 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.98 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.432 ' OG ' ' N ' ' A' ' 167' ' ' ARG . 46.8 t -73.26 179.61 3.83 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.394 -0.922 . . . . 0.0 110.731 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.432 ' N ' ' OG ' ' A' ' 166' ' ' SER . 28.8 ttm105 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 116.418 -1.753 . . . . 0.0 110.803 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.557 ' C ' ' H ' ' A' ' 98' ' ' MET . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.831 0.348 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -68.3 15.9 0.05 OUTLIER 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.405 -0.918 . . . . 0.0 110.975 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.557 ' H ' ' C ' ' A' ' 96' ' ' ALA . 81.6 mmm -124.09 90.49 3.27 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.181 -0.608 . . . . 0.0 110.695 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.457 ' H ' HG13 ' A' ' 99' ' ' ILE . 2.5 pp -96.08 14.34 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 C-N-CA 119.622 -0.831 . . . . 0.0 111.155 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.419 ' C ' ' N ' ' A' ' 102' ' ' LYS . . . -53.39 156.08 5.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.341 -1.409 . . . . 0.0 110.525 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 7.3 m -43.55 -25.0 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 C-N-CA 119.531 -0.867 . . . . 0.0 110.724 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.527 ' O ' ' N ' ' A' ' 105' ' ' ARG . 40.4 mttp -47.69 -37.19 12.5 Favored 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 118.71 -1.196 . . . . 0.0 109.88 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 106' ' ' ASP . 8.7 tt0 -49.18 -49.19 43.78 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 118.401 -1.319 . . . . 0.0 107.632 179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.631 ' CD1' ' CE2' ' A' ' 161' ' ' PHE . 0.2 OUTLIER -49.99 -34.38 20.89 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 102' ' ' LYS . 16.1 ttp180 -63.28 -38.17 90.12 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.079 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.536 ' CG ' ' N ' ' A' ' 107' ' ' ALA . 0.0 OUTLIER -48.95 -48.89 42.65 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 118.592 -1.243 . . . . 0.0 108.181 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.536 ' N ' ' CG ' ' A' ' 106' ' ' ASP . . . -59.82 -56.96 15.23 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 118.795 -1.162 . . . . 0.0 108.195 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.581 ' CZ ' ' N ' ' A' ' 158' ' ' PHE . 1.5 t80 -41.24 -33.52 0.38 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.311 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 29.1 ttt-85 -67.42 -65.74 0.65 Allowed 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 119.304 -0.958 . . . . 0.0 109.871 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -50.33 -30.4 12.01 Favored 'General case' 0 C--N 1.309 -1.191 0 C-N-CA 118.811 -1.155 . . . . 0.0 109.138 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.522 ' CD1' HD13 ' A' ' 119' ' ' ILE . 0.1 OUTLIER -57.26 -50.37 73.1 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.862 179.775 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.643 ' C ' ' H ' ' A' ' 114' ' ' ASN . 16.3 m-20 -95.93 94.72 7.78 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.642 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.9 26.81 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.527 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.643 ' H ' ' C ' ' A' ' 112' ' ' ASP . 0.0 OUTLIER -141.92 -96.9 0.13 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 119.812 -0.755 . . . . 0.0 110.603 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 171.77 38.41 0.03 OUTLIER Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.451 -1.357 . . . . 0.0 110.353 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 117' ' ' GLY . 27.9 p30 -83.5 -29.74 27.72 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.278 -0.969 . . . . 0.0 110.966 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.594 ' N ' ' OD1' ' A' ' 116' ' ' ASP . . . 88.25 6.0 75.31 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.32 -1.419 . . . . 0.0 110.265 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -150.63 133.94 16.27 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.348 -0.941 . . . . 0.0 110.839 179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.554 HG21 HD22 ' A' ' 124' ' ' LEU . 19.0 mt -88.79 111.58 22.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 C-N-CA 118.866 -1.133 . . . . 0.0 109.949 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 124' ' ' LEU . 9.6 t -88.83 155.67 19.41 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.821 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.469 ' HA ' ' CD1' ' A' ' 145' ' ' ILE . 26.4 m -45.51 -56.66 4.84 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.019 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.9 m -48.67 -46.43 40.24 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.72 -1.192 . . . . 0.0 108.905 179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.22 -39.07 78.79 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.091 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.596 ' CB ' HD11 ' A' ' 145' ' ' ILE . 0.1 OUTLIER -54.01 -60.5 3.24 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 118.921 -1.111 . . . . 0.0 109.292 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -44.56 -51.16 9.2 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.757 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.431 ' HA ' ' NH2' ' A' ' 129' ' ' ARG . 75.3 tt0 -63.2 -32.15 73.48 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.026 -1.069 . . . . 0.0 109.194 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 124' ' ' LEU . . . -73.92 -53.54 9.91 Favored 'General case' 0 C--N 1.307 -1.258 0 C-N-CA 119.438 -0.905 . . . . 0.0 109.83 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' MET . . . . . . . . . . . . . 5.0 mtt -61.6 -16.05 44.71 Favored 'General case' 0 C--N 1.31 -1.136 0 C-N-CA 119.002 -1.079 . . . . 0.0 110.226 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.431 ' NH2' ' HA ' ' A' ' 126' ' ' GLU . 32.5 ttm180 -90.84 -23.14 20.66 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.25 -0.98 . . . . 0.0 110.541 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -78.86 -37.57 39.96 Favored 'General case' 0 C--N 1.305 -1.35 0 C-N-CA 119.365 -0.934 . . . . 0.0 110.611 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.607 ' CD1' ' N ' ' A' ' 131' ' ' LEU . 5.9 mp -79.52 -11.86 59.88 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.999 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.8 pp -172.02 165.55 6.25 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.552 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 134' ' ' HIS . . . -145.8 151.06 23.33 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.253 -1.451 . . . . 0.0 110.431 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.478 ' CG ' ' O ' ' A' ' 133' ' ' GLY . 5.3 m-70 -168.34 -99.91 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.702 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -179.39 71.98 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.45 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -107.77 -155.09 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.4 ' C ' ' N ' ' A' ' 139' ' ' ARG . . . -152.42 159.82 28.61 Favored Glycine 0 N--CA 1.49 2.289 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.508 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.464 ' NE2' HG22 ' A' ' 121' ' ' THR . 1.8 t-160 -56.08 -10.43 0.83 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.891 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . 0.4 ' N ' ' C ' ' A' ' 137' ' ' GLY . 4.1 ttm180 -70.87 -47.7 57.83 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.45 -0.9 . . . . 0.0 110.739 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -72.15 -45.0 62.22 Favored 'General case' 0 C--N 1.304 -1.392 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.348 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.2 mt -58.64 -55.82 20.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.134 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -53.75 -45.05 70.47 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.586 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -51.62 -38.8 56.33 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.781 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 9.4 mt -71.7 -37.13 61.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.719 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.596 HD11 ' CB ' ' A' ' 124' ' ' LEU . 15.0 mt -77.9 -20.51 13.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 C-N-CA 119.301 -0.959 . . . . 0.0 110.796 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.6 ttp85 -88.4 -23.17 23.41 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 119.536 -0.866 . . . . 0.0 111.412 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -79.21 -25.17 42.71 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.396 -0.922 . . . . 0.0 111.293 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -91.82 -20.32 6.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.172 -179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.9 t0 -51.79 165.21 0.2 Allowed 'General case' 0 C--N 1.305 -1.352 0 C-N-CA 119.301 -0.96 . . . . 0.0 110.705 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 31.3 tp -159.07 -41.1 0.06 Allowed 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.615 -0.834 . . . . 0.0 110.719 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 0.1 OUTLIER -84.35 13.79 5.05 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.592 -0.843 . . . . 0.0 111.122 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 69.39 38.81 80.86 Favored Glycine 0 N--CA 1.491 2.344 0 C-N-CA 119.389 -1.386 . . . . 0.0 110.572 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -97.38 -83.46 0.39 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.477 -0.889 . . . . 0.0 110.842 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 135.86 14.28 1.01 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.421 ' HD3' ' CB ' ' A' ' 120' ' ' SER . 5.8 mtm-85 -144.51 161.18 39.74 Favored 'General case' 0 N--CA 1.486 1.343 0 C-N-CA 119.783 -0.767 . . . . 0.0 110.924 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 3.2 t -91.57 142.77 12.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 119.279 -0.968 . . . . 0.0 112.101 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.437 ' H ' ' HB2' ' A' ' 160' ' ' GLU . 1.6 m-20 -124.41 160.0 29.17 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.558 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.581 ' N ' ' CZ ' ' A' ' 108' ' ' PHE . 17.2 t80 -41.05 -45.52 2.69 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.185 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -64.49 -60.17 3.46 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.095 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.437 ' HB2' ' H ' ' A' ' 157' ' ' ASP . 35.4 mt-10 -59.12 -29.87 67.7 Favored 'General case' 0 C--N 1.307 -1.243 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.037 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.631 ' CE2' ' CD1' ' A' ' 104' ' ' LEU . 10.1 t80 -74.73 -45.17 45.88 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.407 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.406 HG22 ' HG ' ' A' ' 104' ' ' LEU . 13.5 t -68.0 -29.99 46.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.82 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -81.77 -23.53 36.57 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.586 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.37 -18.29 42.6 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 118.305 -1.358 . . . . 0.0 110.283 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' MET . . . . . . . . . . . . . 6.1 mmt -89.3 -25.14 21.82 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 118.98 -1.088 . . . . 0.0 111.402 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 73.9 m -104.24 -172.18 2.06 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 119.835 -0.746 . . . . 0.0 111.808 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.495 ' HG2' HH11 ' A' ' 167' ' ' ARG . 8.9 tpt180 . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 116.433 -1.746 . . . . 0.0 110.602 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 501' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 502' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_